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The autonomic nervous system is an important modulator of ventricular repolarization and 
arrhythmia vulnerability. This series of investigations aimed to characterize the effects of 
standardized cardiovascular autonomic function tests on ventricular repolarization and 
repolarization heterogeneity, with a special reference to congenital arrhythmogenic 
disorders typically associated with stress-induced fatal ventricular arrhythmias. 
Effects of autonomic adaptation on QT intervals in a 12-lead electrocardiogram and in 
multichannel magnetocardiography were studied in 10 healthy adults during mental stress, 
Valsalva manoeuvre, sustained handgrip, deep breathing, voluntary hyperventilation and 
cold pressor testing. Based on the experience gained from the studies on healthy subjects, 
a series of tests consisting of deep breathing, Valsalva manoeuvre, mental stress, sustained 
handgrip and mild supine exercise testing was subsequently performed in two patient 
groups, while a 25-lead body surface electrocardiogram was recorded. The first series 
comprised 9 asymptomatic patients with LQT1 subtype of the hereditary long QT 
syndrome and 8 healthy controls whereas the second series comprised 9 patients with 
arrhythmogenic right ventricular dysplasia (ARVD) and 9 healthy controls. Automated 
QT interval measurements with a validated computer-based method were used in all 
studies. 
Even strong sympathetic activation had no effects on spatial QT interval dispersion in 
healthy subjects, but deep respiratory efforts and Valsalva manoeuvre influenced it in 
ways that were opposite in electrocardiographic and magnetocardiographic recordings. 
LQT1 patients showed blunted QT interval and sinus nodal responses to sympathetic 
challenge, as well as an exaggerated QT prolongation during the recovery phases. LQT1 
patients showed a QT interval recovery overshoot in 2.4 ± 1.7 tests compared with 0.8 ± 
0.7 in healthy controls (P = 0.02). Valsalva strain prolonged the T wave peak to T wave 
end interval only in the LQT1 patients, considered to reflect the arrhythmogenic substrate 
in this syndrome. ARVD patients showed signs of abnormal repolarization in the right 
ventricle, modulated by abrupt sympathetic activation. An electrocardiographic marker 
reflecting interventricular dispersion of repolarization was introduced. It showed that 
LQT1 patients exhibit a repolarization gradient from the left ventricle towards the right 
ventricle, which was significantly larger than in controls. In contrast, ARVD patients 
showed a repolarization gradient from the right ventricle towards the left. Valsalva strain 
amplified the repolarization gradient in LQT1 patients whereas it transiently reversed the 
gradient in patients with ARVD. 
In conclusion, intrathoracic volume and pressure changes influence regional 
electrocardiographic and magnetocardiographic QT interval measurements differently. 
Especially recovery phases of standard cardiovascular autonomic functions tests and 
Valsalva manoeuvre reveal the abnormal repolarization in asymptomatic LQT1 patients. 
Both LQT1 and ARVD patients have abnormal interventricular repolarization gradients, 
which are modulated by abrupt sympathetic activation. Autonomic testing and in 
particular the Valsalva manoeuvre are potentially useful in unmasking abnormal 
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AP(D) action potential (duration) 
ARVD arrhythmogenic right ventricular dysplasia 
bpm beats per minute 
BSPM body surface potential mapping 
ECG electrocardiogram, electrocardiography, electrocardiographic 
HR heart rate 
HRV heart rate variability 
ICa(L) L-type calcium current 
IK1 inwardly rectifying potassium current 
IKr rapidly activating component of the delayed rectifier potassium current 
IKs slowly activating component of the delayed rectifier potassium current 
INa sodium current 
Ito1, Ito2 transient outward potassium currents 
LQT1(-8) subtypes (1 to 8) of congenital long QT syndrome 
LQTS long QT syndrome 
LV left ventricle 
MAP monophasic action potential 
M cell midmyocardial cell  
MCG magnetocardiogram, magnetocardiography, magnetocardiographic 
QTc rate corrected QT interval (Bazett’s formula) 
QTend the interval from the onset of the Q wave to the end of the T wave 
QTpeak the interval from the onset of the Q wave to the peak of the T wave 
RV right ventricle 
TdP torsade de pointes 
TDR transmural dispersion of repolarization 









Evidence from population studies supports the general belief that strong psychological 
stress increases the incidence of sudden cardiac death (MEISEL ET AL. 1991, LEOR ET AL. 
1996). Anger and physical exertion, both of which cause profound changes in the activity 
of the autonomic nervous system, are important triggers of symptoms in patients at 
known risk for serious ventricular arrhythmias (LAMPERT ET AL. 2002). Sympathetic 
activation brought on by mental stress causes temporal and spatial repolarization 
heterogeneity (i.e. dispersion) in the ventricles of these patients (KOP ET AL. 2004, 
LAMPERT ET AL. 2005). Increased dispersion of repolarization is a fundamental condition 
for ventricular arrhythmogenesis (HAN AND MOE 1964). Thus, direct influences of stress-
induced sympathetic activation on ventricular repolarization and its heterogeneity appear 
to be pivotal mechanisms through which emotional or physical stress may trigger life-
threatening ventricular arrhythmias. 
Most sudden cardiac deaths in the general population are related to manifestations of 
coronary artery disease. However, a significant proportion of sudden cardiac deaths in 
younger populations occur in the absence of apparent heart disease, where congenital 
microscopic or micromolecular defects have brought about a permanent susceptibility to 
life-threatening arrhythmic events. So strong is the triggering role of sympathetic 
activation in many of these conditions that the most commonly known repolarization 
disorder, the congenital long QT syndrome (LQTS), was thought to arise from 
abnormalities of the autonomic nervous system (SCHWARTZ AND LOCATI 1985) before its 
recognition as primarily an ion channel disease. 
In clinical settings, ventricular repolarization abnormalities are usually assessed by 
measuring the duration of the QT interval in the electrocardiogram (ECG) recorded on the 
body surface. Abnormal QT intervals have been linked to sudden death (ALGRA ET AL. 
1991) and cardiac mortality (KARJALAINEN ET AL. 1997). Interlead variability of QT 
measured intervals (spatial QT dispersion) was earlier considered a general marker of 
repolarization heterogeneity (DAY ET AL. 1990). Recent experimental observations have 
underscored the importance of interventricular and especially transmural dispersion of 
repolarization as an arrhythmogenic substrate. Transmural dispersion of repolarization 
manifests on the ECG in the terminal portion of the T wave (YAN AND ANTZELEVITCH 
1998), whereas there are as yet no established clinical markers for interventricular 
dispersion of repolarization. 
 Despite advances in gene technology, simple bedside testing is needed for diagnostic 
and counselling purposes in congenital arrhythmogenic syndromes. Standardized 
autonomic testing could provide an easily applicable tool in delineating arrhythmia 
provoking conditions. Abrupt changes in autonomic activity cause marked changes in QT 
interval adaptation even in healthy subjects (TOIVONEN ET AL. 1997), however, making 
the recognition of abnormal repolarization a difficult task.  
The present series of investigations attempts to outline autonomic effects on 
traditional as well as proposed new ECG markers of repolarization and its heterogeneity. 
Sophisticated body surface recordings and automated QT interval measurements were 






function tests, both in healthy subjects and in two patient groups with known hereditary 






2 Review of the literature 
2.1 The cardiovascular autonomic nervous system 
2.1.1 Anatomy and physiology 
The cardiovascular autonomic nervous system maintains circulatory homeostasis of the 
organism, ensuring adequate tissue perfusion under varying environmental and internal 
demands. This rapid adaptation of the circulation is mainly accomplished through reflex 
arcs: Mechano- and chemosensory input from different systemic and central receptors are 
conveyed by afferent nerve fibres to medullary centres for integration, and efferent fibres 
in turn transmit impulses from the central nervous system to the heart and blood vessels, 
modulating their activity. The medullary centres also receive input from higher brain 
centres and the hypothalamus, important for instigating cardiovascular responses to 
emotion, stress and exercise. 
Anatomically and functionally the autonomic nervous system is divided into the 
sympathetic and the parasympathetic divisions. The efferent limbs of both divisions 
consist of myelinated preganglionic nerve fibers connecting with unmyelinated 
postganglionic fibres in synaptic clusters called ganglia. Postganglionic fibres in turn 
innervate the effector organs.  
 
Sympathetic nervous system. Preganglionic sympathetic fibres arise in the lateral 
horns of the spinal segments T1-L3 (WALLIN AND CHARKOUDIAN 2007). Most 
preganglionic fibres travel only a short distance in the spinal nerve, before branching off 
into the sympathetic ganglia which are arranged as two paravertebral chains (truncus 
sympaticus) extending from the cervical to the sacral region. Some fibres only traverse 
these sympathetic ganglionic chains, synapsing in separate cervical (the cervical or the 
stellate) or abdominal (the celiac or the mesenteric) ganglia (HARATI AND MACHKHAS 
1997). The chemical neurotransmitter in sympathetic presynaptic nerve endings is 
acetylcholine. In most postsynaptic nerve endings, the transmitter is noradrenaline. Some 
preganglionic fibers traveling in the greater mesenteric nerve synapse with chromaffin 
cells in the adrenal medulla. Stimulation of these cholinergic preganglionic fibers results 
in the release of adrenaline and to a lesser extent noradrenaline into the bloodstream. The 
actions of adrenaline and noradrenaline are mediated by specific G-protein coupled 
adrenergic receptors on the surface of the cell. Pharmacologically, these adrenoceptors 
are divided into α and ß receptors. Two main subtypes of α receptors (α1, α2) and three 
main subtypes of ß receptors (ß1, ß2, ß3) have been identified (Table 1) (BRISTOW ET AL. 
1990, INSEL 1996, BOSCH ET AL. 2002). 
 
Parasympathetic nervous system. Parasympathetic outflow arises in the motor nuclei 
of cranial nerves III, VII, IX and X in the brainstem and from the spinal segments S2-S4. 






organ (HARATI AND MACHKHAS 1997). The chemical neurotransmitter in both pre- and 
postsynaptic parasympathetic nerve endings is acetylcholine (cholinergic nerve fibres). 
The actions of acetylcholine are mediated by nicotinic and muscarinic acetylcholine 
receptors (Table 1). The nicotinic receptors are ligand-gated ion channels, mediating the 
effects of acetylcholine in the autonomic ganglia. The muscarinic receptors are G-protein 
coupled receptors, mediating the parasympathetic impulses to the effector organs. 
 
Table 1. Cholinergic and adrenergic receptors of the autonomic nervous system. 
Receptor type 
Agonists and order of 
potency 
Antagonists Main locations 
Cholinergic    
nicotinic acetylcholine, 
nicotine >> muscarine 
hexamethonium postsynaptic neurons of autonomic 
ganglia (synaptic transmission), 




muscarine >> nicotine 
atropine, 
scopolamine 
heart, vascular and nonvascular smooth 
muscle, glands, CNS 
Adrenergic    
α1 phenylephrine, 
A = NA >> ISO 
doxazosin vascular and nonvascular smooth 
muscle, heart, CNS 
α2 clonidine, 
A = NA >> ISO 
yohimbine presynaptic (inhibition of transmitter 
release), vascular smooth muscle, 
platelets, CNS 
ß1 dobutamine, 





ISO > A >> NA 
butoxamine vascular and nonvascular smooth 
muscle, skeletal muscle, heart 
ß3 BRL 37344, 
ISO = A > NA 
SR59230A adipose tissue, heart 
A = adrenaline, NA = noradrenaline, ISO = isoprenaline, CNS = central nervous system 
 
Innervation of the heart. Postganglionic sympathetic nerves travelling to the heart 
arise in the right and left stellate ganglia and the caudal halves of the cervical sympathetic 
trunks (JANES ET AL. 1986). Sympathetic nerves arising from the right stellate ganglia are 
more likely to supply the anterior regions whereas those from the left stellate ganglia are 
more likely to supply the inferoposterior regions of the heart (YANOWITZ ET AL. 1966, 
JANES ET AL. 1986). Parasympathetic fibres travel to the heart in the vagus nerves. Also 






atria are more densely innervated than the ventricles and the basal areas of the ventricles 
are more densely innervated than the apical areas (KAWANO ET AL. 2003). The right and 
left ventricles show similar nerve distributions, however. There are slightly more 
parasympathetic than sympathetic nerve fibres in the atria, whereas the ventricles have a 
sparse parasympathetic innervation (NAPOLITANO ET AL. 1965) but notably more 
sympathetic fibres (KAWANO ET AL. 2003). Sympathetic innervation is denser in the 
anterior as compared with the posterior parts of the ventricles (MOMOSE ET AL. 2001). 
There are more sympathetic nerves in the subepicardium than in the subendocardium, 
whereas there are more parasympathetic nerves in the subendocardium than in the 
subepicardium (KAWANO ET AL. 2003). Thus, autonomic innervation of the heart shows 
both transepicardial and transmural heterogeneities, which may carry functional 
significance in pathological circumstances.  
 
Innervation of blood vessels and the arterial baroreflex. All blood vessels except the 
capillaries are innervated. The sympathetic nervous system controls the tone of vascular 
smooth muscle mainly through the vasoconstrictive effects of α1-adrenergic stimulation 
and the vasodilating effects of ß2-adrenergic stimulation. Blood vessels of skeletal muscle 
contain also vasodilating cholinergic sympathetic fibres. Only visceral, cranial and 
genitourinary blood vessels exhibit direct parasympathetic innervation, but muscarinic 
receptors sensitive to vasodilatation through exogenous acetylcholine are found widely in 
vascular smooth muscle and endothelium. Thus, the autonomic nervous system directly 
controls peripheral resistance and the distribution of blood flow and perfusion of organs 
by modulating the tone of the smooth muscle in arteries and capacitance vessels.  
Changes in transmural arterial pressure are sensed by numerous stretch-receptors 
called baroreceptors, located mainly in the aortic arch and the carotid sinus. Afferent 
impulses from the baroreceptors are conducted to cardioinhibitory and vasomotor centres 
in the medulla, resulting in inhibition of sympathetic and excitation of parasympathetic 
structures.  Increased arterial pressure leads thus to decreased peripheral resistance and 
increased capacity of the capacitance vessels, as well as to decreased heart rate (HR) and 
myocardial contractility, resulting in decreased cardiac output and arterial blood pressure. 
Arterial pressure reduction, on the other hand, has opposite effects.  This autoregulatory 
mechanism constitutes a control circuit where reflex changes in neuronal output triggered 
by the baroreceptors in response to sudden changes in blood pressure functions to rapidly 
restore initial conditions (LANFRANCHI AND SOMERS 2002). Local circulatory effects of 















Table 2. Circulatory effects of sympathetic and parasympathetic activation. 
 Sympathetic Parasympathetic 
Sinoatrial node HR ↑ (ß1, ß2) HR ↓ (M2) 
Atrial muscle contractility ↑ (ß1, ß2) contractility ↓ (M2) 
Atrioventricular node conduction ↑ (ß1) conduction ↓ (M2) 
Ventricular muscle contractility ↑ (ß1, ß2) - 
Vascular smooth muscle vasoconstriction (α1) 
vasodilation (ß2, M3) 
- 
See Table 1 for description of the receptors in parentheses. 
2.1.2 Cardiovascular autonomic function testing 
Heart rate variability and respiratory sinus arrhythmia. Beat-to-beat alterations in 
cardiac cycle length are referred to as HR variability (HRV). HRV is strongly coupled to 
respiration: HR increases during inspiration and decreases during expiration. The afferent 
limb of the reflex arc responsible for this respiratory sinus arrhythmia conveys input from 
arterial baroreceptors, low-pressure receptors in the heart and probably stretch receptors 
in the lungs (MELCHER 1976). The efferent limb of the reflex arc is vagal (WHEELER AND 
WATKINS 1973).  
HRV may be assessed during either spontaneous breathing or during breathing cued at 
a specific frequency. It can be quantified with time-domain, frequency-domain and 
nonlinear indices, giving estimates of the relative contributions of parasympathetic and 
sympathetic control (TASK FORCE 1996). Parasympathetic activity is associated with 
decreased HR and increased HRV, whereas sympathetic activity conveys opposite effects.  
Perhaps the most widely utilized test of parasympathetic function is the deep 
breathing test (WHEELER AND WATKINS 1973). The subject breathes deeply and slowly, 
usually at 6 breaths per minute using subjective maximal vital capacity, maximizing the 
magnitude of respiratory sinus arrhythmia. The difference between maximum and 
minimum HRs during a respiratory cycle (deep breathing difference) is calculated, and 
usually the mean of 4-6 successive differences is used as an index of HRV. Decreased 
HRV during controlled breathing is considered a sensitive marker of parasympathetic 
dysfunction. HRV decreases with age, but is not affected by gender or mean HR (SMITH 
AND SMITH 1981). 
 
Valsalva manoeuvre. The Valsalva manoeuvre is usually performed by blowing 
against a pressure of 5.3 kPa (40 mmHg) for 15 seconds. This forced expiration against 
resistance elevates the intrathoracic pressure, causing a distinct series of reflex 
cardiovascular responses. In normal subjects, these can be divided into four phases. 






pressure, sometimes accompanied by a brief slowing of HR. As strain continues, the 
blood pressure falls progressively, due to impeded venous return (phase 2), causing reflex 
acceleration of HR. Ventricular dimensions reduce and the stroke volume falls by almost 
30% during the strain (ROBERTSON ET AL. 1977, FELDMAN ET AL. 1985). Immediately 
after the cessation of strain, the blood pressure continues to fall due to the sudden 
decrease in intrathoracic pressure (phase 3). Improved venous return while the HR 
remains elevated then quickly raises the blood pressure, leading to marked reflex 
bradycardia (phase 4). The mechanisms of these circulatory responses are related to the 
baroreflex: Tachycardia during phases 2 and 3 are mainly due to combined 
parasympathetic withdrawal and sympathetic stimulation (LEON ET AL. 1970, BENNETT ET 
AL. 1976), while the bradycardia during phase 4 is a result of increased parasympathetic 
activity (BENNETT ET AL. 1976). The strain also induces direct sympathetic neural 
activation that is apparently independent of the baroreflex mechanisms (COOKE ET AL. 
2003). Valsalva manoeuvre thus causes abrupt sympathetic activation, followed by reflex 
parasympathetic activation, occurring together with significant changes in cardiac filling. 
HR responses during Valsalva are often described with indices of R-R interval 
changes. The Valsalva ratio (LEVIN 1966) is defined as the ratio of the longest R-R 
interval during phase 4 divided with the shortest interval during strain. The bradycardia 
ratio (BENNETT ET AL. 1978) is defined as the longest R-R interval after strain divided 
with the resting R-R interval. The tachycardia ratio (BALDWA AND EWING 1977) is 
calculated as the shortest R-R interval during strain divided by the longest R-R interval 
before strain. These ratios are considered to reflect parasympathetic control of HR.  
  
Sustained handgrip. During isometric exercise, impulses from motor areas of the brain 
and muscle receptors cause a generalized increase in sympathetic outflow to blood vessels 
and the heart. These responses are usually studied during isometric handgrip, usually held 
at 30% of maximal voluntary contraction. During handgrip HR increases first as a result 
of vagal withdrawal and later due to both vagal withdrawal and sympathetic stimulation 
(MARTIN ET AL. 1974). The amplified sympathetic outflow to the heart enhances cardiac 
contractility (SHEPHERD ET AL. 1981). Vasoconstriction occurs in resistance and 
capacitance vessels, whereas vasodilatation occurs in cutaneous vessels (SHEPHERD ET AL. 
1981). Cardiac output increases, elevating both systolic and diastolic blood pressure, 
while the total peripheral resistance remains relatively constant (LIND ET AL. 1964). 
Levels of plasma noradrenaline and adrenaline increase about twofold and fivefold, 
respectively (STRATTON ET AL. 1983). Clinically, the response to isometric exercise is 
used as a measure of sympathetic integrity: A diminished blood pressure elevation in 
response to handgrip is considered indicative of sympathetic neuropathy. 
  
Cold pressor test. The cold pressor test, usually immersion of a limb in iced water, has 
been used in cardiovascular research to elicit a rapid blood pressure increase. Cold 
immersion elevates arterial blood pressure, HR and vascular resistance (GREENE ET AL. 
1965). HR increase is usually limited to the early part of immersion; it appears to be 
related to pain and is mediated mainly by sympathetic activation (VICTOR ET AL. 1987). 






to blood vessels (VICTOR ET AL. 1987). Plasma catecholamine levels usually increase only 
slightly (STRATTON ET AL. 1983). 
Face immersion in cold water is considered to represent the dive reflex in humans. It 
is associated with increase in muscle sympathetic nerve activity and causes an initial 
increase and a subsequent decrease of HR; the latter due to both vagal activation and 
inhibition of sympathetic activity (FAGIUS AND SUNDLÖF 1986).  
 
Mental stress. Cardiovascular responses to psychological stress are linked to the 
aetiology and prognosis of several cardiovascular disorders and a wide range of mental 
stress tests have therefore been used in cardiovascular research (STEPTOE AND VÖGELE 
1991). The most commonly used methods consist of problem-solving or information-
processing tasks, e.g. mental arithmetic or colour-word conflict testing. Mental stress 
elevates HR, blood pressure and stroke volume, but causes only a slight decrease or no 
change in vascular resistance (HJEMDAHL ET AL. 1984, GROSSMAN ET AL. 1989) and 
ejection fraction (BECKER ET AL. 1996). Hemodynamic responses are mainly thought to 
reflect increases in circulating adrenaline (adrenal response): Levels of plasma adrenaline 
but not of noradrenaline increase during mental stress testing (SAITOH ET AL. 1995, 
GROSSMAN ET AL. 1989, GOLDBERG ET AL. 1996). 
 
Orthostatic and baroreflex testing. The change of posture from supine to upright leads 
to decreased venous return as a result of blood pooling to the blood vessels of the trunk 
and lower extremities. This leads to a transient fall in cardiac output and blood pressure, 
rapidly corrected by the baroreflex through peripheral vasoconstriction and accelerated 
HR. Normal subjects have a biphasic initial HR response: An immediate increase 
followed by a transient decrease. The initial tachycardia is mediated mainly by vagal 
withdrawal with concomitant slight sympathetic activation whereas the rebound 
bradycardia is of vagal origin (EWING ET AL. 1980). Continued upright posture is 
associated with persistent increase in efferent sympathetic activity. Orthostatic tests are 
performed either as active standing or with a tilt table, but the elicited responses are 
fundamentally different between these methods (WIELING ET AL. 1985). Orthostatic tests 
are useful in the assessment of orthostatic intolerance, vasovagal syncope and integrity of 
sympathetic function.  
Baroreflex sensitivity can be assessed by measuring the instantaneous HR responses 
to sudden changes in blood pressure. The linear relationship of systolic blood pressure 
and R-R interval can be measured during reflex changes induced by phenylephrine 
infusion or Valsalva manoeuvre (AIRAKSINEN ET AL. 1993). Decreased baroreflex 
sensitivity is considered to reflect parasympathetic dysfunction. 
 
Autonomic adaptation during physical exercise. Physical exercise is associated with 
an increase of sympathetic activity and a withdrawal of parasympathetic activity, 
resulting in increased blood pressure, HR and cardiac contractility. Physical exercise 
induces a mainly sympathetic nervous as opposed to an adrenal response, as suggested by 
the notably greater increases observed in plasma noradrenaline than in adrenaline 






profound hemodynamic changes and greater elevation of plasma catecholamines than 
mental stress, sustained handgrip or cold pressor testing (SAITOH ET AL. 1995, STRATTON 
ET AL. 1983). 
2.2 Ventricular repolarization 
2.2.1 Membrane currents and the cardiac action potential 
Resting myocardial cells exhibit negative membrane potentials (-85 to -95 mV). 
Electrical stimulation of the cell induces opening of voltage-gated ion channels and influx 
of positive ions (cations) into the cell, thereby depolarizing it and initiating the cardiac 
action potential (AP). Depolarization propagates to adjacent cells through gap junctions, 
by this means conducting the activation to all cells of the heart, causing intracellular 
calcium ion release and ultimately myocardial contraction. Repolarization, on the other 
hand, is an intrinsic property of the cells that occurs regardless of the existence of 
conducting junctions. 
 
Classically, the cardiac AP is divided into five phases numbered from 0 to 4 (Figure 1). 
Phase 0 is the rapid upstroke of the AP, when fast sodium channels open causing an 
influx of Na+ ions (the fast sodium current, INa) thus depolarizing the cell. Repolarization 
occurs in three phases: Phase 1 represents the initial brief downward deflection of the AP, 
marking the inactivation of INa and activation of the transient outward potassium currents 
(Ito1 and Ito2). Some myocytes exhibit a prominent AP notch during phase 1. Phase 2 is the 
plateau of the AP, upheld mainly by a balance of inflow of calcium ions through L-type 
calcium channels (ICa(L)), inflow of sodium ions due to late INa, and outflow of potassium 
ions through channels responsible for the slowly (IKs) and rapidly (IKr) activating 
components of the delayed rectifier current. Phase 3 represents the final rapid 
repolarization of the cell, when ICa(L) channels close while IKs channels remain open. The 
ensuing negative change in membrane potential promotes further opening of potassium 
channels, augmenting IKr and the inwardly rectifying potassium current (IK1), accelerating 
restoration of the resting potential. Phase 4 is the interval between end of repolarization 
and the beginning of the next AP. The major currents of the cardiac action potential are 








Figure 1. Phases of the ventricular action potential (see text for details). 
 
Table 3. Major ionic currents responsible for the ventricular action potential. 
Current Ion Genes AP phase 
INa Na+ SCN5A 0, 1, 2 
ICa(L) Ca2+ CACNA1C 0, 1, 2 
Ito K+ KCND2/KCND3 1 (notch) 
IKs K+ KCNQ1 + KCNE1 2, 3 
IKr K+ KCNH2 (hERG) + KCNE2 2, 3 
IK1 K+ KCNJ2/KCNJ12/KCNJ4 3 
Bold indicates the action potential phase during which the majority of the current occurs. AP = action 
potential. 
2.2.2 Measurement 
Repolarization time. AP duration (APD) represents the time interval between the onset of 
phase 0 to the onset of phase 4. It is common to measure APD to the point of 90% 
repolarization, because the exact point of complete repolarization is difficult to identify. 
Repolarization time is the sum of the activation time and the local APD. APD 






cells or with floating microelectrodes on tissue wedges. Multiple simultaneous recordings 
over a greater area can be performed by optical mapping with voltage-sensitive dyes and 
photodiode arrays or CCD-cameras (EFIMOV ET AL. 1994). These methods are constrained 
to in vitro settings.  
Monophasic action potential (MAP) recordings are usually obtained with contact 
electrode catheters and they measure the potential difference between the electrode and 
adjacent myocardial cells (an injury current). MAP recordings give reliable estimates of 
the time-course of local transmembrane APs (FRANZ ET AL. 1986). Local repolarization 
can also be measured from local unipolar electrograms. While the MAP waveforms 
resemble transmembrane APs, unipolar electrograms exhibit distinct QRS and T waves 
like surface ECGs. Estimation of repolarization from unipolar electrograms is usually 
done by measuring the activation-recovery interval, commonly defined as the time 
between the minimum first derivative of the QRS complex and the maximum derivative 
of the T wave. In the absence of ischemia, activation-recovery intervals reflect 
transmembrane APDs under various physiological conditions (HAWS AND LUX 1990). 
Unipolar electrograms can be obtained with needle electrodes (MILLAR ET AL. 1985), 
conventional electrode catheters (XIA ET AL. 2005a) or with noncontact multielectrode 
arrays (YUE ET AL. 2005). 
 
Refractory period. During phase 2 and the beginning of phase 3, an additional 
electrical stimulus is not able to instigate another AP. This is referred to as the effective 
refractory period. APD and the recovery of excitability show a close temporal correlation 
under non-ischemic conditions (LEE ET AL. 1992), therefore the effective refractory period 
is often used as a measure of repolarization duration. Classically, the effective refractory 
period is measured with the extrastimulus technique, where regular basic pacing trains 
(S1) are followed by premature stimuli (S2) at progressively shorter coupling intervals, 
and defined as the shortest extrastimulus interval that captures (HAN AND MOE 1964). 
Normally this occurs at approximately 70% repolarization of the preceding steady state 
AP. Activation intervals during ventricular fibrillation have also been used as a measure 
of refractoriness in experimental settings (OPTHOF ET AL. 1991). 
2.2.3 Modulating factors 
Cycle length and diastolic interval (AP restitution).  The most important physiological 
determinant of APD is the cardiac cycle length. Generally, a reduction in cycle length 
shortens the APD. In humans, steady-state APD shows a linear correlation with cycle 
length, except at very long cycle lengths (FRANZ ET AL. 1988). After a sudden change in 
basic cycle length APD first shortens or lengthens abruptly, followed by a more gradual 
change that reaches a new steady state after a few minutes (FRANZ ET AL. 1988).  
APD is dependent not only on the preceding cycle length, but also on the duration of 
the preceding diastolic interval (BASS 1975, FRANZ ET AL. 1983). The adaptation of APD 
to (abrupt) changes in the diastolic interval is referred to as APD restitution. Usually the 






the extrastimulus technique, where the APD is plotted against the diastolic interval at 
different S1-S2 coupling intervals at a given stable S1 rate. Electrical restitution curves in 
humans show a characteristic triphasic shape (FRANZ ET AL. 1988): The duration of the 
most premature AP is markedly reduced, increasing steeply at progressively longer S1-S2 
intervals to an initial maximum occurring at 50-150 ms after the effective refractory 
period. Thereafter it shortens again at growing S1-S2 intervals (completing a “hump”), 
before gradually prolonging again to a maximum occurring at around 1000 ms (FRANZ ET 
AL. 1988). Thus, the relationship between APD and cycle length is different whether 
assessed at a steady HR, after a sudden but sustained change in HR or after a premature 
stimulus. 
Incomplete recovery of membrane currents and ion accumulation are probable 
mechanisms responsible for rate dependent APD shortening (BOYETT AND JEWELL 1978). 
The immediate AP adaptation is thought to be a result of increased IKs, because it 
accumulates during rapid pacing, thus changing from a transient to a more constant 
current (LU ET AL. 2001). Simulation studies suggest that the relative densities of IKs and 
IKr importantly affect the rate adaptation of APD (ZENG ET AL. 1995, VISWANATHAN ET 
AL. 1999). However, the role of IKs at physiological HRs in humans has been debated: It 
has been observed not to contribute significantly to APD in the absence of sympathetic 
stimulation or compromised repolarization (diminished repolarization reserve) (VOLDERS 
ET AL. 2003, JOST ET AL. 2005). Other simulation studies have suggested that Ito1 and ICa(L) 
are important for APD rate adaptation (HUND AND RUDY 2004). 
 
Autonomic effects. Catecholamines modulate repolarization mainly by augmenting 
ICa(L) (VELDKAMP ET AL. 2001) and IKs (SANGUINETTI ET AL. 1991). In isolated cells, 
activation of ß-receptors abbreviates whereas activation of α-receptors prolongs APD 
(GIOTTI ET AL. 1973). Priori and Corr reported that small concentrations of isoprenaline 
prolonged whereas larger concentrations markedly abbreviated APD (PRIORI AND CORR 
1990). In accordance with these experimental observations, ß-adrenergic stimulation 
shortens and α-adrenergic stimulation prolongs the ventricular effective refractory period 
in humans (MORADY ET AL. 1988, WEISS ET AL. 1998). Adrenaline infusion steepens the 
APD restitution curves both in experimental models (TAGGART ET AL. 1990) and in 
humans (TAGGART ET AL. 2003), meaning that adrenergic stimulation alters the 
relationship between HR and timing of repolarization.  
Due to marked discrepancy between in vivo and in vitro findings, it was long debated 
whether acetylcholine had any direct effects on APD in ventricular myocytes. Litovsky 
and Antzelevitch then discovered that although acetylcholine had little if any effect on 
APD in isolated endocardial cells, small concentrations of acetylcholine prolonged and 
large concentrations markedly abbreviated APD in isolated epicardial cells (LITOVSKY 
AND ANTZELEVITCH 1990).  
 Direct stimulation of the right or left stellate sympathetic ganglion abbreviates left 
ventricular refractory periods, whereas stellate ganglionectomy prolongs them 
(YANOWITZ ET AL. 1966, MARTINS AND ZIPES 1980). These effects are not necessarily 
universal, because ganglion stimulation can also induce a prolongation of refractoriness in 






AL. 1991). In isolated rabbit hearts with intact dual autonomic innervation, direct 
stimulation of sympathetic nerves steepened the APD restitution slope and increased the 
susceptibility of the preparation to ventricular fibrillation (NG ET AL. 2007). In the same 
preparations, direct stimulation of vagal nerves flattened the APD restitution slope and 
raised the ventricular fibrillation threshold. During simultaneous stimulation of 
sympathetic and parasympathetic nerves, the shortening effect of the former has been 
observed to dominate (INOUE AND ZIPES 1987). 
Combined, these previous findings demonstrate that the effects of autonomic 
adaptation on ventricular repolarization can be difficult to predict. In the intact organism, 
autonomic reflexes involve complex and combined neural and humoral changes. In 
addition, the autonomic nervous system modulates APD indirectly through simultaneous 
changes in HR. 
 
Activation-recovery coupling and cardiac memory. Activation time and APD show a 
close negative correlation, with shorter APDs occurring at sites activated later (FRANZ ET 
AL. 1987). This inverse coupling of activation and repolarization, observed both at steady 
state and after premature stimulation, may act to preserve electric stability in the normal 
ventricle (YUE ET AL. 2005). The dependence of repolarization on preceding activation 
patterns is referred to as cardiac memory (COSTARD-JÄCKLE ET AL. 1989). Several 
molecular mechanisms are probably involved, among others changes in Ito, ICa(L) and IKr 
(ROSEN AND COHEN 2006). While memory effects are considered reversible, permanent 
functional changes to sustained abnormal activation patterns has been referred to as 
electrical remodelling (VOS ET AL. 1998). 
 
Other factors. Any factor modulating the transmembrane ionic currents active during 
the cardiac AP has the potential to affect repolarization. These include among others 
ischemia (DOWNAR ET AL. 1977, TAGGART ET AL. 1988a, LUKAS AND ANTZELEVITCH 
1993), cardiac and noncardiac drugs (TAMARGO ET AL. 2004), changes in ion homeostasis 
(especially hypokalemia) (ANTZELEVITCH ET AL. 1991), gender and sex hormones (HARA 
ET AL. 1998, JAMES ET AL. 2007), and mutations or polymorphisms of genes encoding ion 
channel proteins (SPLAWSKI ET AL. 2000, SANGUINETTI AND TRISTANI-FIROUZI 2006). In 
addition, mechanical stretch of myocardial fibres directly modulates APD, a phenomenon 
referred to as mechanoelectric feedback (LAB 1982, FRANZ ET AL. 1992).  
2.2.4 Dispersion  
Dispersion of ventricular repolarization denotes the degree of spatial or temporal 
inhomogeneity in repolarization times or refractoriness and is classically defined as the 
difference between the longest and shortest measured time interval. Although increased 
dispersion of repolarization is usually associated with pathological states, some degree of 
physiological dispersion of repolarization is apparent under normal conditions as a result 







Transmural dispersion of repolarization.  Ventricular muscle contains three main 
types of excitable cells, namely endocardial, midmyocardial (M) and epicardial cells 
(SICOURI AND ANTZELEVITCH 1991, ANTZELEVITCH ET AL. 1991) Owing to differences in 
ion channel densities their electrophysiological properties differ, causing heterogeneity in 
the shape and behaviour of APs within the ventricular wall. APs of epicardial cells show a 
more prominent phase 1 notch than endocardial cells, due to a more prominent Ito in the 
former, giving epicardial APs a spike-and-dome appearance (ANTZELEVITCH ET AL. 
1991). APDs are also shorter in epicardial than in endocardial cells at fast to moderate 
stimulation rates. M cells exhibit longer APDs and a steeper AP rate dependence 
(manifesting as greater prolongation with slowing of rate) than epicardial or endocardial 
cells (SICOURI AND ANTZELEVITCH 1991, YAN ET AL. 1998). These differences are 
ascribed to weaker IKs and larger late INa in M cells than in endocardial or epicardial cells 
(LIU AND ANTZELEVITCH 1995, VISWANATHAN ET AL. 1999, ZYGMUNT ET AL. 2001, 
SZABO ET AL. 2005), resulting in decreased repolarization current during phases 2 and 3 of 
the AP. Therefore agents or conditions that reduce IKr or augment late INa produce a much 
greater prolongation of M cell APD (weak IKs and strong late INa → less total repolarizing 
current) than of epicardial or endocardial APD (strong IKs and weak late INa → more total 
repolarizing current). This amplifies transmural dispersion of repolarization (TDR) 
(SHIMIZU AND ANTZELEVITCH 1997, EMORI AND ANTZELEVITCH 2001). Reduced IKs, 
however, amplifies TDR only in the presence of ß-adrenergic influence, due to a larger 
augmentation of residual IKs in epicardial and endocardial cells than in M cells (SHIMIZU 
AND ANTZELEVITCH 1998). 
Most current knowledge of TDR stems from studies on cells isolated from the 
different myocardial layers or from experiments on canine perfused ventricular wedge 
preparations. Although transmural repolarization gradients have been observed in vivo 
(EL-SHERIF ET AL. 1996, MEROT ET AL. 1999), several studies have failed to detect such 
gradients at physiological HRs (BAUER ET AL. 1999, JANSE ET AL. 2005, TAGGART ET AL. 
2001). It has been suggested that strong electrotonic coupling by gap junctions hides the 
electrophysiological manifestations of M cells under normal conditions (CONRATH ET AL. 
2004). Others have suggested that the M cells may be a transient functional state rather 
than a distinct anatomical subset of cells (UEDA ET AL. 2004). Marked AP prolongation in 
M cells causing augmented TDR nevertheless becomes evident in abnormal conditions 
associated with increased arrhythmia susceptibility, such as LQTS and heart failure 
(AKAR ET AL. 2002, AKAR AND ROSENBAUM 2003). 
 
Apicobasal dispersion of repolarization. The direction and magnitude of apicobasal 
repolarization gradients have varied in different experimental settings (isolated cells vs. 
intact hearts) and in different species. In isolated canine and human hearts apical APDs 
are shorter than basal APDs, presumably due to twice larger densities of Ito and IKs in 
apical than in basal myocytes (SZENTADRASSY ET AL. 2005). In the rabbit heart, isolated 
cells from the apex show longer APDs than in isolated cells from the base (CHENG ET AL. 
1999). In intact hearts, an APD gradient from base to apex has been observed in the pig 
(DEAN AND LAB 1990), whereas the opposite has been observed in the dog (BAUER ET AL. 






repolarization times in posteroapical areas of the intact canine left ventricle (JANSE ET AL. 
2005).  
 
Interventricular dispersion of repolarization. In experimental studies, APs of the left 
ventricle (LV) are longer than those of the right ventricle (RV) (DI DIEGO ET AL. 1996, 
VERDUYN ET AL. 1997a, VOS ET AL. 1998). Epicardial (DI DIEGO ET AL. 1996) and M cells 
(VOLDERS ET AL. 1999) from LV exhibit smaller Ito and IKs densities than those from RV, 
contributing to the repolarization gradient from LV to RV. 
  
Alternans. A change in an amplitude or time interval of the electrogram that repeats 
every other beat is referred to as electrical alternans. Beat-to-beat alternation of APD is a 
rate dependent intrinsic property of myocardial cells that occurs above a critical threshold 
HR (PASTORE ET AL. 1999), probably reflecting time dependent recovery kinetics of 
transmembrane ionic currents. Abnormalities in e.g. ICa(L) and Ito have been implicated 
(LUKAS AND ANTZELEVITCH 1993). Alternation with opposite phase between 
neighbouring cells (discordant alternans) produces spatial repolarization gradients 
(PASTORE ET AL. 1999).  
 
Rate dependence. Global dispersion of repolarization does not show HR dependence 
at steady state (LAURITA ET AL. 1996, ZABEL ET AL. 1997). Premature stimulation 
significantly augments dispersion, however (MERX ET AL. 1977, KUO ET AL. 1983, 
LAURITA ET AL. 1998). Considerable heterogeneity of AP restitution kinetics has been 
observed both across the epicardium (LAURITA ET AL. 1996) and transmurally 
(ANTZELEVITCH ET AL. 1991). APD in epicardium is shorter than in endocardium at rapid 
stimulation rates but longer at slower rates (LITOVSKY AND ANTZELEVITCH 1989), 
whereas M cells show considerably steeper rate dependence than either epicardial or 
endocardial cells (SICOURI AND ANTZELEVITCH 1991) potentially affecting TDR.  
  
Autonomic effects. Han with co-workers observed that stimulation of cardiac 
sympathetic nerves increased whereas infusion of catecholamines decreased the 
dispersion of the recovery of excitability (HAN AND MOE 1964, HAN ET AL. 1964). Opthof 
et al. observed similarly that left, right or combined stellate stimulation could increase the 
dispersion of refractoriness, but not necessarily in every heart (OPTHOF ET AL. 1991). 
Regional differences have also been observed in response to right or left vagus nerve 
stimulation, most notably a failure of the anterior RV to respond to vagal stimulation 
despite significant prolongation of repolarization elsewhere (MARTINS ET AL. 1983). In 
the rabbit heart, however, bilateral autonomic nerve stimulation (both sympathetic and 
vagal) caused a reversal of the repolarization sequence between apex and base, a 
phenomenon not observed during pharmacological autonomic stimulation (MANTRAVADI 
ET AL. 2007). Yoshioka et al. studied the effects of noradrenaline infusion and direct 
stellate stimulation on activation recovery intervals in the in situ rabbit heart after 
regional denervation with topical phenol (YOSHIOKA ET AL. 2000). They observed 






noradrenaline. However, during stellate stimulation a shortening was observed in only 
30% and a prolongation in 70% of the regions.  
Also transmural differences in responses to autonomic challenge exist, as suggested 
by the observation that epicardium is more sensitive than endocardium to the APD-
modulating effects of acetylcholine and isoproterenol (LITOVSKY AND ANTZELEVITCH 
1990). However, in an in vivo canine experiment, sympathetic stimulation reduced TDR 
by causing a greater abbreviation of MAPs in the M region than in epicardium or 
endocardium (TAKEI ET AL. 1999).  
Dispersion of repolarization is thus significantly influenced by regional changes in 
sympathetic innervation and by dynamic changes in autonomic activity. Furthermore, 
different types of autonomic stimulation (neural or humoral) may cause dissimilar 
responses. 
 
Other modulating factors. Hypothermia and regional warm blood perfusion increases 
dispersion of ventricular repolarization (KUO ET AL. 1983). Ischemia increases both 
spatial and transmural dispersion of APDs (KIMURA ET AL. 1988, LUKAS AND 
ANTZELEVITCH 1993), an effect further augmented by adrenergic stimulation (TAGGART 
ET AL. 1988b). In ischemic conditions, repolarization alternans has been observed to be 
related to cyclic changes in TDR occurring as a result of an alternating loss of the AP 
dome in epicardium but not in endocardium (LUKAS AND ANTZELEVITCH 1993). 
Pharmacologic blockade of transmembrane currents modulates transmural (SHIMIZU AND 
ANTZELEVITCH 1998, WU ET AL. 2005), apicobasal (BAUER ET AL. 2002) and 
interventricular (VAN OPSTAL ET AL. 2001, VERDUYN ET AL. 1997b) dispersion of 
repolarization. Changes in ion homeostasis may amplify transmural (WOLK ET AL. 1998) 
and apicobasal (WOLK ET AL. 2002) dispersion of repolarization. Mechanical factors such 
as acute left ventricular dilatation (REITER ET AL. 1988) and sustained left ventricular load 
(ZABEL ET AL. 1996) can increase dispersion of repolarization, possibly due to 
augmentation of apicobasal gradients (DEAN AND LAB 1990). Ventricular hypertrophy is 
associated with increased spatial (KOWEY ET AL. 1991), interventricular (VOS ET AL. 
1998) and transmural (YAN ET AL. 2001a) dispersion of repolarization. Also gender-
related transmural differences in ionic currents may exist (XIAO ET AL. 2006) contributing 
to TDR. Reversing the activation sequence to occur from the epicardium towards the 
endocardium (e.g. epicardial pacing) augments TDR (FISH ET AL. 2004). 
2.2.5 Pathophysiological significance of repolarization  
The refractory period and its adaptation to cycle length serve two important physiological 
functions. First, it prevents compounded APs such as occurs in skeletal muscle (tetanus). 
Second, the refractoriness of recently activated myocardial cells prevents circular 
reactivation, known as re-entry. 
The development of re-entry requires the presence of unidirectional block within a 
conducting pathway and sufficiently slow conduction to enable recovery of excitability to 






presence of an anatomical obstacle has been considered a prerequisite for re-entry. 
However, re-entry may occur even in the absence of anatomical obstacles if temporal 
differences in recovery of excitability are large enough (ALLESSIE ET AL. 1976). 
Functional unidirectional block then develops transiently during the absolute refractory 
period, whereas the necessary slowing of conduction occurs due to encroachment into the 
relative refractory period. In this way, steep repolarization gradients may create 
conditions facilitating re-entry (KUO ET AL. 1983, KUO ET AL. 1985, LAURITA AND 
ROSENBAUM 2000).  
In keeping with these inferences, increased spatial dispersion of ventricular 
repolarization is associated with a susceptibility to ventricular arrhythmias (VASSALLO ET 
AL. 1988, MISIER ET AL. 1995, YUAN ET AL. 1995, CHAUHAN ET AL. 2006). Increased 
TDR is associated with re-entrant ventricular arrhythmias in a variety of congenital and 
acquired conditions (SHIMIZU AND ANTZELEVITCH 1998, AKAR AND ROSENBAUM 2003, 
FENICHEL ET AL. 2004, EXTRAMIANA AND ANTZELEVITCH 2004), underlining that 
potentially arrhythmogenic local re-entrant circuits may arise transmurally. Increased 
interventricular dispersion of repolarization has been associated with the occurrence of 
ventricular arrhythmia (VERDUYN ET AL. 1997b, VERDUYN ET AL. 1997a, VOS ET AL. 
2000) and arrhythmic sudden death (VAN OPSTAL ET AL. 2001) in animal models. 
Electrical alternans is common in patients at increased risk for ventricular arrhythmias 
(ROSENBAUM ET AL. 1994, GOLD ET AL. 2000). 
Exaggerated prolongation of APs favours the development of early 
afterdepolarizations. These can also be induced by ß-adrenergic stimulation (PRIORI AND 
CORR 1990). The polymorphic ventricular tachyarrhythmia usually associated with AP 
prolongation, torsade de pointes (TdP), is considered to be triggered by premature 
ventricular beats arising from early afterdepolarizations (EL-SHERIF ET AL. 1988, YAN ET 
AL. 2001b), with increased TDR serving as a substrate for re-entry (EL-SHERIF ET AL. 
1996, EL-SHERIF ET AL. 1997, YAN ET AL. 2001b). 
The autonomic nervous system affects conduction velocity and APD – crucial 
determinants for re-entry – as well as the occurrence of early afterdepolarizations. Thus, 
alterations in autonomic activity can modulate both the substrate and the trigger for 
arrhythmia, through effects on ventricular repolarization.  
2.3 Projections of repolarization on the body surface 
2.3.1 ECG and MCG 
At any given instant during cardiac excitation there are potential differences between 
excited and unexcited regions, therefore the electrical behaviour of the heart has often 
been described as a dipole. The orientation of such a dipole changes during the spread of 
excitation, and the ensuing potential changes can be detected with appropriately placed 
electrodes on the body surface. Recorded as a function of time, these potential changes 






electrode causes a positive deflection on the ECG whereas a vector moving away from 
the exploring electrode causes a negative deflection. Activation wavefronts perpendicular 
to the exploring electrode are seen as isoelectric. ECG leads in contact with the heart are 
called direct, leads close to the heart (less than two cardiac diameters) are called 
semidirect and leads further away are called indirect. In bipolar leads, both the positive 
and negative electrodes face similar potential variations. In unipolar leads, the negative 
(by definition) electrode faces negligible potential variations compared with the positive 
electrode; the direction of the exploring positive electrode is thus radially outward from 
the centre of the heart. 
The standard 12-lead ECG has three limb leads (I, II and III), three augmented limb 
leads (aVR, aVL and aVF) and six precordial leads (V1-V6). All of these leads are 
effectively bipolar (KLIGFIELD ET AL. 2007), although especially the precordial leads are 
commonly described as being unipolar. Being relatively distant, all limb leads are 
indirect. In the standard limb leads, one limb electrode is connected to the negative and 
the other to the positive terminal of the recorder. In the augmented limb leads, all three 
limb electrodes are connected to the negative terminal; a combination of two of these 
leads then serves as the negative electrode (“Goldberger central terminal”) whereas the 
remaining one connected to the positive terminal serves as the exploring electrode. 
Exclusion of the potential of the exploring lead from the central terminal “augments” the 
signal. Precordial leads (V1-V6) are semidirect, because the exploring electrodes are 
placed on the chest wall. They are connected to the positive terminal, whereas electrodes 
from right arm, left arm and left leg are all connected to the negative terminal (“Wilson 
central terminal”). An electrode placed on the right leg is earthed to minimize 
interference. 
A low frequency filter (high-pass filter) is commonly applied to the signal to reduce 
wandering of the baseline, such as that caused by breathing movements. A high frequency 
filter (low-pass filter) can be used to minimize higher frequency noise. If the low 
frequency cut-off is set too high, it may distort the signal in areas with abrupt change of 
frequency content and wave amplitude. If the high frequency cut-off is set too low, it may 
cause inaccuracy in the assessment of QRS amplitudes and detection of small waveforms. 
A low frequency cut-off at 0.05 Hz and a high frequency cut-off at 150 Hz has been 
recommended for use in routine settings (KLIGFIELD ET AL. 2007). 
The spatial sampling of surface ECG may be extended from the standard 12-lead 
positions to body surface potential mapping (BSPM) systems consisting of up to over a 
hundred chest leads. This widespread torso sampling facilitates better detection of local 
cardiac events (MIRVIS 1987) and has revealed that the electrical behaviour of the heart is 
more complex than a simple dipole. BSPM recordings are often presented as isopotential 
maps instead of traditional scalar waveforms, further emphasizing the localizing power of 
increased spatial sampling.  
Magnetocardiography (MCG) measures the weak magnetic fields generated by the 
same potential changes, and consequently the MCG exhibits similar morphological and 
temporal features as the ECG (SAARINEN ET AL. 1978). Theoretically, ECG is more 
sensitive to radial currents, whereas MCG is more sensitive to tangential currents. In heart 






circumstances contain information of complementary nature to that of ECG (SILTANEN 
1989, LANT ET AL. 1990).  
2.3.2 Cellular basis of the T and U waves 
It is generally accepted that the T wave in ECG represents repolarization gradients within 
the ventricles. The shape and duration of the T wave is affected both by the sequence of 
recovery across the ventricular and by differences in AP duration between different areas 
of the ventricles (VAN DAM AND DURRER 1964). In normal conditions, the QRS and T 
wave polarities are concordant, suggesting that normal ventricular electrical recovery 
occurs from the epicardium towards the endocardium (BURGESS ET AL. 1972, BURGESS 
1979, FRANZ ET AL. 1987). Studies have shown also apico-basal (NOBLE AND COHEN 
1978) and epicardial (COWAN ET AL. 1988a) repolarization gradients to be related to the T 
wave configuration. 
The experimental studies of Yan and Antzelevitch (YAN AND ANTZELEVITCH 1998) on 
canine left ventricular wedge preparations brought new insight on the genesis of the T 
wave. They described that voltage gradients between M cells and epi/endocardial cells 
contribute prominently to the shape of the T wave on a pseudo-ECG measured across the 
ventricular wall. T wave onset occurred when phase 2 of the epicardial AP separated from 
that of the M region, and T wave peak occurred when the repolarization of the epicardium 
was complete. Voltage gradients between M cells and endocardial cells (opposite to those 
between M cells and epicardial cells) limited the amplitude of the T wave, and outlined 
the initial part of the descending limb of the T wave. The end of the T wave coincided 
with full repolarization of the M region. These findings indicate that local T wave 
morphology is influenced more by transmural than transventricular repolarization 
gradients. Direct in vivo validation of this theory is lacking, however (XIA ET AL. 2005b). 
The origin and physiological significance of the U wave remains unresolved. It has 
been suggested to arise from afterdepolarizations (LEPESCHKIN 1957), the Purkinje 
network (WATANABE 1975), M cells (DROUIN ET AL. 1995) and from mechanoelectric 
events (SURAWICZ 1998). Recently, it was shown that catecholamine infusion causes 
distinct alterations in the duration and amplitude of the U wave, differing from the effects 
on the T wave, underlining that the U wave represents a component of cardiac 
repolarization that is electrocardiographically and physiologically distinct from the T 
wave (MAGNANO ET AL. 2004). Small U waves and large U waves may have a different 
origin, however. In a number of pathological conditions a low amplitude T wave is 
followed by prominent U wave. Experimental studies suggest that the forces responsible 
for such pathologic U waves are similar to those responsible for the T wave, indicating 
that the latter is likely a second component of a bifid T wave. Also clinical observations 
support this view (VIITASALO ET AL. 2006), suggesting that it would be more appropriate 






2.3.3 QT interval measurement 
The QT interval is considered to reflect the time from earliest activation to latest 
repolarization of ventricular myocardium and to represent the sum of all transmembrane 
APs in a given axis (VAUGHAN WILLIAMS 1982). In most clinical settings, measurement 
of the QT interval from the ECG remains the method of choice to assess perturbations of 
ventricular repolarization. However, no consensus exists as to the precise methodology 
and lead selection in QT interval measurements. Moreover, manual QT measurements 
show considerable intraobserver variation (AHNVE 1985), making comparisons between 
different studies even more difficult. The term QT interval generally refers to the time 
interval from the beginning of the Q wave to the end of the T wave (QTend). It is 
methodologically easier to measure the interval to the peak of the T wave (QTpeak), but 
its information content is different (YAN AND ANTZELEVITCH 1998, DAVEY 1999a).  
 
Lead selection. In clinical studies, the QT interval has been measured from the lead in 
which the QT interval is longest, from the lead where the T wave is most prominent or its 
descending limb steepest, from lead aVL or II where the U wave is usually flat, or from a 
lead with a distinct initial Q wave (CAMPBELL ET AL. 1985). Various lead selections may 
give different results (SADANAGA ET AL. 2006). Based on their risk stratification study in 
families with congenital LQTS, Mönnig et al. suggested using lead II if measurable, and 
V5 as a second choice (MÖNNIG ET AL. 2006). Others have suggested using one of the 
leads V3-V4 (SADANAGA ET AL. 2006) or V2-V3 (KAUTZNER 2002). Using the average of 
all measured leads or a superimposition of simultaneously recorded leads may overcome 
problems of lead selection. 
 
QRS onset. Timing of QRS onset varies slightly between different ECG leads 
(COWAN ET AL. 1988b). Resulting interlead variability of QT duration, whether real or 
artefact, may be eliminated by selecting the earliest QRS onset in any lead when 
assessing several synchronously recorded leads.  
 
QTpeak. Identification of the peak of the T wave is usually straightforward, but 
difficulties may arise if the T wave is flat. Biphasic T waves are often excluded from 
measurements altogether, but this may seriously compromise the recognition of 
repolarization abnormalities. In such cases various strategies have been used, with T wave 
peak defined as the first peak, the second peak, or the highest of the peaks.     
 
QTend. The end of the T wave is usually defined as the point where its descending 
limb meets the baseline, or alternatively, the point where a tangent fitted on the steepest 
downward slope of the T wave crosses the baseline. The latter method may somewhat 
underestimate the duration of the QT interval, but it is usable at higher HRs when the end 
of the T wave may be interrupted by the P wave. Both methods are, however, sensitive to 
drift of the isoelectric baseline. U waves should be excluded, but sometimes a notched or 
biphasic T wave may be mistakenly defined as a U wave. If the second apex occurs ≤ 150 






1952, LEHMANN ET AL. 1994). Partial fusion of the U wave with the terminal portion of 
the T wave is problematic. Lepeschkin and Surawicz, in the perhaps the most frequently 
cited study on the methodology of QT measurement (LEPESCHKIN AND SURAWICZ 1952), 
suggested using the tangent method on the descending limb of the T wave in the case of 
partial T-U fusion. Many investigators, however, define the nadir between the curves as 
the end of the T wave. 
  
To overcome intra- and interobserver variation of QT measurements, several 
computer-based automatic methods have been introduced. Many of these have proven 
reproducible, practical and user-independent (SAVELIEVA ET AL. 1998a, OIKARINEN ET AL. 
1998). However, some algorithms may have technical sources of error (MCLAUGHLIN ET 
AL. 1995, SMITH ET AL. 2003) and automated methods may be less reliable in cardiac 
patients than in healthy controls (MCLAUGHLIN ET AL. 1996), particularly in the case of 
difficult T wave morphologies (GLANCY ET AL. 1996a). It has been suggested that 
automated measurements may not significantly improve the accuracy of QT 
measurements, due to the inherent difficulties in identifying the end of the T wave 
precisely (KAUTZNER 2002). 
2.3.4 Modulation of the QT interval 
2.3.4.1 Rate dependence 
HR is the most important determinant of QT interval duration. Normally, an increase in 
HR abbreviates the QT interval, whereas a decrease in HR prolongs it. Changes in QT 
duration in response to HR change are dependent on both instantaneous cycle length and 
on the duration of the prevailing HR (SEED ET AL. 1987). After a change in HR it can take 
up to two minutes for the QT interval to reach a new steady state (LAU ET AL. 1988). The 
QT interval and HR relation exhibits hysteresis phenomenon, probably related to 
concomitant changes in autonomic activity as well as to a time-dependency of QT 
interval adaptation to rapid change in cycle length (ARNOLD ET AL. 1982, SARMA ET AL. 
1987).  
A QT interval that is normal at a given HR may thus be abnormal at another. 
Therefore a number of normalization formulas have been utilized. Most of them are 
expressed in the form QTc = QT/RRα, where QT is the measured QT interval and RR is 
the measured cycle length in seconds. Such formulas normalize the QT interval to the 
cycle length of 1 second, attempting to describe what the QT interval would have been, 
had it been measured at a HR of 60 beats per minute (bpm). The calculated QTc interval 
may then be compared to a defined normal range without further attention to the 
measured QT interval or the prevailing HR. The most widely used formulas are the ones 
introduced by Bazett (α = 0.5) (BAZETT 1920) and Fridericia (α = 0.333) (FRIDERICIA 
1920). Other approaches involve e.g. a linear regression equation (QTc = QT + 0.154[1 – 






(KARJALAINEN ET AL. 1994). A major limitation of any general formula attempting to 
normalize for HR is that the QT/RR dependence shows substantial interindividual 
variability (MALIK ET AL. 2002). However, as QT/RR dependence at the same time 
exhibits a high intraindividual stability, some authors have suggested that subject-specific 
rate correcting formulas should be used (BATCHVAROV ET AL. 2002). 
During physical exercise the QT-HR relationship may be characterized by a linear 
regression equation (VIITASALO ET AL. 1996, KLIGFIELD ET AL. 1996). The slope of this 
equation (ranging from around -1.3 to -1.7 ms/beats/min in normal subjects) can be used 
as a measure of HR dependency of the QT interval.   
2.3.4.2 Autonomic nervous system 
The autonomic nervous system influences QT interval duration both directly and 
indirectly through changes in HR. The role of changes in autonomic activity in the 
modulation of QT duration has been studied by observing effects of 1) direct stimulation 
or interruption of cardiac nerves in animal experiments 2) drugs that stimulate or block 
cholinergic or adrenergic receptors 3) physiological manoeuvres that invoke reflex 
changes in autonomic activity (e.g., cardiovascular autonomic function tests) and 4) 
observing the relationship between QT changes and other markers of autonomic activity, 
e.g. from ambulatory ECG recordings. 
 
Direct neural effects. Brief electrical stimulation of cardiac sympathetic nerves 
prolongs the QT interval, but prolonged stimulation abbreviates it (ABILDSKOV 1976). 
Interruption of sympathetic innervation by stellate ganglionectomy prolongs the QT 
interval, but effects of right or left stellate innervation show functional and regional 
differences (YANOWITZ ET AL. 1966). Stimulation of sympathetic nerves modulates the 
QT/RR relationship both at steady-state and during rapid rate adaptation (ZAZA ET AL. 
1991) whereas no direct parasympathetic effects have been observed (MALFATTO ET AL. 
1993). 
 
Pharmacological autonomic effects. Rapid infusion of adrenaline (α/ß1/ß2 agonist) 
transiently prolongs the QT interval, whereas slow infusion shortens it (ABILDSKOV 
1976). Slow intravenous infusions of isoprenaline (ß1/ß2 agonist) (CUOMO ET AL. 1997, 
BALAJI ET AL. 1997, LOWE ET AL. 2001) and salbutamol (ß2 agonist) (LOWE ET AL. 2001) 
abbreviate QT duration. Magnano et al. observed that the QT interval shortened less 
during isoprenaline infusion than during exercise or atropine, after a similar increase in 
HR (MAGNANO ET AL. 2002). They also observed that QT-HR slopes were similar during 
exercise and atropine infusion, but were significantly less steep during isoprenaline 
infusion. Infusion of catecholamines may cause marked changes in T and U wave 
morphologies even in healthy subjects, complicating the interpretation of QT responses 
(MAGNANO ET AL. 2006). During atrial pacing, atropine and atropine plus propranolol 
shorten the QT interval independently of HR (AHNVE AND VALLIN 1982, BROWNE ET AL. 






on the other hand, has no effect on QT duration at steady HR (BROWNE ET AL. 1982). 
Pharmacologic blockade at the level of sympathetic and parasympathetic ganglia has also 
been shown to prolong the QT interval (DIEDRICH ET AL. 2002). 
 
Autonomic reflexes and exercise. QT duration varies with breathing phase, but it has 
been suggested that this is secondary to the cyclic changes in R-R intervals rather than a 
result of direct vagal modulation of repolarization (EMORI AND OHE 1999). Kautzner et al. 
reported that reflex parasympathetic activation induced by a phenylephrine bolus did not 
modulate the QTend or QTpeak interval, when HR was kept constant by atrial pacing 
(KAUTZNER ET AL. 1997).  
During dynamic exercise, QT duration shortens linearly with increasing HR but shows 
considerable hysteresis during recovery, possibly related to autonomic effects (SARMA ET 
AL. 1987, SUNDQVIST AND SYLVÉN 1989). In addition, a paradoxical early prolongation of 
QT duration in response to exercise has been described in patients with permanent 
pacemakers (COGHLAN ET AL. 1992), possibly related to the mechanism of transient 
prolongation seen during rapid adrenaline infusion (ABILDSKOV 1976). Mental stress 
testing abbreviates the QT interval even when HR remains constant, as shown in patients 
with high-degree atrioventricular block (HEDMAN AND NORDLANDER 1988). Paavonen et 
al. observed that the measured QT intervals shorten during mental stress testing, but to a 
lesser degree than during physical exercise at comparable HR (PAAVONEN ET AL. 2001). 
 In a study by Davidowski and Wolf (DAVIDOWSKI AND WOLF 1984), dynamic 
exercise was associated with considerable changes in both HR and QT interval, whereas 
Valsalva manoeuvre, dive reflex, hyperventilation, breath-holding and cold pressor 
testing showed only minimal or no change in QT duration, despite significant changes in 
HR. As a result, the use of QTc intervals was concluded to yield paradoxical results 
during reflex manoeuvres. Similarly, sustained handgrip has been reported to shorten the 
QT interval in healthy patients (DE CAPRIO ET AL. 1986), whereas others have reported 
QTc prolongation (DAVEY 1999b, FREDERIKS ET AL. 2001). It follows that the use of HR 
correction formulas is inappropriate when studying the effects of autonomic manoeuvres 
or stimulation on QT duration. This makes the interpretation and comparison of most 
previous studies difficult, as studies reporting in detail the behaviour of uncorrected QT 
intervals during autonomic testing are scarce.  
 Davidowski and Wolf further suggested that HR and QT interval may be governed by 
different sympathetic fibres. Similar conclusions were drawn in the study of Arrowood et 
al., examining normal subjects and cardiac transplant patients during exercise, Valsalva 
and the cold pressor test (ARROWOOD ET AL. 1993). Furthermore, their results suggested 
that during exercise, the QT interval was regulated primarily by increases in circulating 
catecholamines rather than neurally mediated reflex autonomic changes.  
 
Ambulatory recordings. QT intervals in hearts with an intact autonomic innervation 
show a diurnal variation, whereas such variation is blunted in transplanted hearts and 
absent in diabetic autonomic neuropathy (BEXTON ET AL. 1986). It has been observed that 
QT intervals are longer during sleep than during comparable HRs in the waking state, 






(VIITASALO AND KARJALAINEN 1992, MURAKAWA ET AL. 1992). Maximum QTc duration 
and QTc variability generally occur shortly after awakening, possibly due to autonomic 
instability at this time (MOLNAR ET AL. 1996). Arousal reactions during ambulatory 
recordings are associated with marked inertia of QT interval adaptation to HR (TOIVONEN 
ET AL. 1997). These observations underline the difficulties in interpreting QT intervals 
measured in uncontrolled settings. It has been suggested that changes in autonomic 
activity may be taken into account by plotting QT intervals against R-R intervals 
measured at similar basic HRs during different physiological conditions (VIITASALO AND 
KARJALAINEN 1992).  
2.3.4.3 Other factors 
Women generally exhibit longer QT intervals than men (BAZETT 1920, RAUTAHARJU ET 
AL. 1992). It has been shown that women exhibit steeper QT/HR slopes than men during 
isoprenaline and atropine infusions (MAGNANO ET AL. 2002) as well as during exercise 
(KLIGFIELD ET AL. 1996, MAGNANO ET AL. 2002, CHAUHAN ET AL. 2002). Women also 
exhibit steeper QTpeak/RR and QTend/RR slopes than men in ambulatory ECG 
recordings (OIKARINEN ET AL. 1998). Recent findings have indicated that there are gender 
differences in the QT responses to sympathetic stimulation, as observed during mental 
stress (INSULANDER AND VALLIN 2005) and in response to isoprenaline infusion 
(NAKAGAWA ET AL. 2005). 
Plasma electrolyte disturbances are known to influence the QT interval; 
hypocalcaemia and hypokalemia prolong whereas hypercalcaemia and hyperkalemia 
generally shorten it. Fever abbreviates the QT interval independently of HR 
(KARJALAINEN AND VIITASALO 1986). Changes in ventricular loading may alter the QT 
interval (TAGGART ET AL. 1992) possibly related to mechanoelectric feedback (LAB 
1982). A vast number of both cardiac (e.g., sotalol, quinidine, ibutilide, disopyramide, 
amiodarone) and noncardiac (e.g., macrolide antibiotics, several antipsychotics and 
antidepressants) drugs are known to prolong the QT interval (see www.torsades.org).  
2.3.5 Spatial QT dispersion 
2.3.5.1 Background and definition  
The observation that interlead QT interval variation is greater in patients with heart 
disease than in controls (SYLVEN ET AL. 1984, MIRVIS 1985) and its association with 
arrhythmia risk (DAY ET AL. 1990) led to the hypothesis that QT dispersion reflects 
dispersion of ventricular refractoriness. The association between QT dispersion and 
dispersion of ventricular repolarization was validated in an experimental study, 
comparing multiple simultaneous MAP recordings with simulated 12-lead ECG in 






adopted as a non-invasive method of measuring spatial dispersion of repolarization from 
body surface recordings, giving rise to a large number of studies on the diagnostic, 
prognostic and therapeutic value of this measure in both cardiac and non-cardiac 
conditions. 
QT dispersion is classically quantified as the difference between the maximum and 
the minimum QT interval in any lead (DAY ET AL. 1990). To diminish the influence of 
single outliers and measurement error, the standard deviation (DAVEY ET AL. 1994) and 
the coefficient of variability (relative QT dispersion) (PRIORI ET AL. 1994) of QT intervals 
in all leads have also been used. 
2.3.5.2 Measurement 
There is no universally accepted standard method for QT dispersion measurement, but 
the principles of QT interval measurement generally apply to dispersion measurements as 
well. Simultaneous measurement of all leads is preferred, but probably not mandatory in 
resting measurements due to the lag in QT adaptation to HR change. Rate correction 
should not be used, because neither the dispersion of APs (ZABEL ET AL. 1997) nor QT 
dispersion (ZAREBA AND MOSS 1995) is HR dependent. Generally, QT intervals should be 
assessed from all available leads, but it is common practice to exclude leads in which the 
T wave is not well defined. The minimum number of accepted leads has varied among 
studies, but the numerical values of QT dispersion generally become smaller when the 
number of included leads is reduced. Significant differences between study groups have 
been detected using only the six precordial leads (HII ET AL. 1992) or even as few as three 
leads (GLANCY ET AL. 1995a). It has been proposed that QT dispersion should be adjusted 
to compensate for missing leads, by dividing with the square root of the number of 
measurable leads (DAY ET AL. 1991). However, this may distort the results; instead it has 
been suggested that unadjusted QT dispersion should be reported together with the 
number of accepted leads (GLANCY ET AL. 1995b). 
Reproducibility of QT dispersion measurements has been a matter of concern, having 
low short-term reproducibility as well as significant interobserver errors in manual 
measurements (KAUTZNER ET AL. 1994). Automatic assessment of QT intervals eliminates 
observer bias, but has not solved the reproducibility problems of QT dispersion 
measurements (GLANCY ET AL. 1996a, SAVELIEVA ET AL. 1998a). However, in serial 
measurements on the same subject, the automatic method appears more reproducible than 
manual assessment (SAVELIEVA ET AL. 1998b). 
2.3.5.3 Modulating factors 
Physiological and chemical factors. QT dispersion was found not to be influenced by age 
or gender in a large sample of healthy subjects (MACFARLANE ET AL. 1998), although 
others have reported that males exhibit slightly more QT dispersion than females in 






that both maximum expiration and maximum inspiration reduced QT dispersion by about 
20% compared with normal breathing (KRUPIENICZ ET AL. 1997). In contrast, Gang and 
coworkers observed that QT dispersion was unaffected by respiration phase and posture 
(GANG ET AL. 1998). Sinus arrhythmia was observed not to influence QT dispersion in 
healthy children (TUTAR ET AL. 1998). A sudden decrease in ventricular filling brought 
about by altering the atrioventricular pacing mode increased QT dispersion in subjects 
with abnormal ventricular function but not in subjects with normal ventricles (JAMES ET 
AL. 2002). An increase in afterload during phenylephrine infusion increased QT 
dispersion independently of changes in HR or vagal activity (YEE ET AL. 2000). 
Hypoglycaemia increased QT dispersion in patients with type 2 diabetes (LANDSTEDT-
HALLIN ET AL. 1999). One study reported that hypokalemia increased QT dispersion, 
whereas hyperkalemia, hypocalcaemia or hypercalcaemia had no significant effects 
(YELAMANCHI ET AL. 2001). 
 
Influences of the autonomic nervous system. Two studies have reported increased QT 
dispersion in diabetics with autonomic dysfunction and abnormal scintigraphic patterns of 
cardiac sympathetic innervation (WEI ET AL. 1995, SHIMABUKURO ET AL. 1996). One of 
these studies (SHIMABUKURO ET AL. 1996) found a correlation between QT dispersion and 
cardiac adrenergic denervation whereas the other did not (WEI ET AL. 1995). Patients with 
primary autonomic failure, however, have no greater QT dispersion than controls despite 
prolonged QT intervals (LO ET AL. 1996). In healthy subjects, diurnal changes in QT 
dispersion have been observed to correlate with HRV indices reflecting increased 
sympathetic or decreased vagal activity (ISHIDA ET AL. 1997).  
Neither reflex parasympathetic activation to a bolus of intravenous phenylephrine 
(KAUTZNER ET AL. 1997) nor parasympathetic blockade with atropine changed QT 
dispersion (YEE ET AL. 2000) in healthy subjects. Intravenous adrenaline, however, 
increased QT dispersion in healthy male subjects (LEE ET AL. 2003), and salbutamol and 
isoprenaline infusions increased QT dispersion both in patients with coronary artery 
disease and in healthy controls (LOWE ET AL. 2001).  
Sympathetic activation elicited by sustained handgrip augmented a number of other 
ECG parameters describing dispersion of repolarization, but QT interval dispersion did 
not change significantly (VAN HUYSDUYNEN ET AL. 2004). The Valsalva manoeuvre was 
observed not to modify QT dispersion in healthy subjects (GHURAN ET AL. 2000). Reports 
on effects of sympathetic activation elicited by orthostatic stress are conflicting: Some 
investigators have observed increased QT dispersion during tilt testing (NAKAGAWA ET 
AL. 1999) whereas others have observed reduced QT dispersion in the standing compared 
with the supine posture (GHURAN ET AL. 2000). Orthostatic stress brought about by leg 
lowering, on the other hand, has been observed not to modify QT dispersion (VAN 
HUYSDUYNEN ET AL. 2004). Physical exercise has been reported to reduce QTpeak 
dispersion (CHAUHAN ET AL. 2002) whereas QTend dispersion has been reported not to 
change (ZABEL ET AL. 2000). In patients with coronary artery disease, QT dispersion has 
been shown to increase during mental stress testing (JAMES ET AL. 2000) and the strain 







Cardiac diseases. Increased QT dispersion has been observed in a great number of 
pathological circumstances, e.g. acute myocardial infarction (GLANCY ET AL. 1996b), left 
ventricular dysfunction (ZAIDI ET AL. 1997, BONNAR ET AL. 1999), left ventricular 
hypertrophy (DAVEY ET AL. 1994, PERKIÖMÄKI ET AL. 1996), hypertrophic 
cardiomyopathy (ZAIDI ET AL. 1996), arrhythmogenic right ventricular dysplasia (BENN 
ET AL. 1999) and LQTS (PRIORI ET AL. 1994). Moreover, changes in QT dispersion have 
been reported to follow the dynamics of the underlying pathological processes. QT 
dispersion shows dynamic changes during acute myocardial infarction (GLANCY ET AL. 
1996b) as well as induced ischemia in chronic coronary artery disease (SPORTON ET AL. 
1997, MICHELUCCI ET AL. 1996, KOIDE ET AL. 2000, CARLUCCIO ET AL. 2003). Treatment 
has been shown to reduce QT dispersion in some disease states, e.g. in response to 
reperfusion after thrombolysis (MORENO ET AL. 1994) or revascularization (KELLY ET AL. 
1997) in myocardial infarction, drug treatment of heart failure (BROOKSBY ET AL. 1999, 
BONNAR ET AL. 1999), regression of left ventricular hypertrophy after antihypertensive 
therapy (KARPANOU ET AL. 1998) and ß-blockade in patients with LQTS (PRIORI ET AL. 
1994).  
2.3.5.4 Clinical significance 
The prognostic value of QT dispersion with respect to mortality and adverse events has 
been studied extensively. Pooling a large number of studies on patients with or without 
ventricular arrhythmias in various cardiac diseases revealed a significantly greater QT 
dispersion in patients with arrhythmia, but the values of dispersion largely overlapped 
(MALIK AND BATCHVAROV 2000). Some large epidemiological studies have found 
increased QT dispersion a predictor of mortality (OKIN ET AL. 2000, PADMANABHAN ET 
AL. 2003) whereas others have not (BRENDORP ET AL. 2001, SHAH ET AL. 2004). Increased 
QTpeak dispersion was observed to be an independent risk factor for sudden cardiac 
death in middle aged men with otherwise normal ECG (MÄNTTÄRI ET AL. 1997). The 
large variation and overlap of the results in the studies have precluded the establishment 
of any meaningful reference values for QT dispersion (MALIK AND BATCHVAROV 2000). 
Lately, the pathophysiological basis of QT dispersion has been questioned (MALIK 
AND BATCHVAROV 2000). A growing body of evidence suggests that QT dispersion is not 
only dependent on intrinsic spatial properties of the repolarization process, but also on the 
projection of the repolarization vector in different ECG leads. It has been suggested that 
QT dispersion mainly arises from variations in the T loop morphology and its variable 
projections into individual ECG leads (KORS ET AL. 1999). Recent investigations have 
shown a poor correlation between surface QT measurements and local ventricular 
refractoriness (VOSS ET AL. 2005) as well as between dispersion of repolarization and 
dispersion of QT intervals (FULLER ET AL. 2000, LIANG ET AL. 2005). Consequently, QT 
dispersion has been proposed to be an indirect measure of general repolarization 
abnormalities, rather than a marker of spatial repolarization inhomogeneity (MALIK AND 






2.3.6 ECG manifestations of transmural dispersion 
Experimental studies have indicated that the T wave peak to T wave end interval (TPE) 
represents the difference between the longest (M cells) and shortest (epicardial cells) AP 
durations across the ventricular wall (YAN AND ANTZELEVITCH 1998) and can thus be 
considered as the ECG counterpart of TDR (SHIMIZU AND ANTZELEVITCH 1997, SHIMIZU 
AND ANTZELEVITCH 1998, SHIMIZU AND ANTZELEVITCH 2000). This concept (presented 
schematically in Figure 2) is supported by evidence from clinical studies in patients with 
congenital LQTS (LUBINSKI ET AL. 1998, TANABE ET AL. 2001, VIITASALO ET AL. 2002a, 
TAKENAKA ET AL. 2003), in post myocardial infarction patients susceptible to ventricular 
tachycardia (OIKARINEN ET AL. 2001) and in high risk patients with organic heart disease 
(WATANABE ET AL. 2004). TPE was recently observed to correlate with the risk of TdP 
during acquired bradyarrhythmias (TOPILSKI ET AL. 2007). It is also prolonged in patients 
with left ventricular hypertrophy (SABA ET AL. 2005). However, some recent studies have 
reported findings suggesting that TPE is a more general measure of repolarization 
dispersion rather than a specific marker of TDR (XIA ET AL. 2005c, OPTHOF ET AL. 2007). 
 
Figure 2. Schematic presentation of action potentials from epicardium (epi), endocardium 
(endo) and midmyocardium (M) together with a simultaneous ECG tracing, 
demonstrating that the T wave peak to T wave end interval (TPE) is the ECG 
counterpart of transmural dispersion of repolarization (TDR).  QTpeak = Q wave to 
T wave peak interval, QTend = Q wave to T wave end interval. 
2.3.7 ECG manifestations of interventricular dispersion 
In BSPM recordings QT intervals have distinctive spatial distributions consistent with 
regional myocardial electrophysiological properties, with longer QT intervals recorded 
over the left lateral thorax and shorter intervals over the right inferior thorax (MIRVIS 






precordial ECG leads than in right precordial leads (HLAING ET AL. 2005).  In the same 
study it was observed that systemic hypertension with left ventricular hypertrophy 
increased the QT difference between right and left precordial leads whereas pulmonary 
hypertension decreased the difference. These observations suggest that it may be possible 
to obtain an ECG index describing interventricular dispersion of repolarization.  
2.3.8 Other ECG markers of repolarization heterogeneity 
QT variability. QT duration exhibits beat-to-beat variability. Berger et al. introduced a 
means to quantify QT variability normalized to HRV (i.e., QT fluctuation not attributed to 
change in HR) by using a QT variability index (BERGER ET AL. 1997). This index has 
been shown to be increased in heart diseases associated with increased risk of arrhythmia 
and sudden cardiac death (BERGER ET AL. 1997, GALEANO ET AL. 2003, BILCHICK ET AL. 
2004). Temporal variability of QT duration has also been quantified using the standard 
deviation of QT intervals, showing a distinct diurnal pattern with increased variability in 
the morning hours (BONNEMEIER ET AL. 2003), similar to those of sympathetic activity 
and the incidence of ventricular arrhythmias. 
 
T wave alternans. Cyclic beat-to-beat variation of T wave amplitude, morphology or 
polarity is referred to as T wave alternans and is considered the ECG manifestation of AP 
alternans (PASTORE ET AL. 1999). T wave alternans associates with increased 
repolarization heterogeneity and susceptibility to ventricular arrhythmias (ROSENBAUM ET 
AL. 1994, CHAUHAN ET AL. 2006). Rashba et al. reported the magnitude of T wave 
alternans to be influenced by sympathetic but not parasympathetic activity (RASHBA ET 
AL. 2002). Exercise and mental stress testing induces T wave alternans in patients at high 
risk for malignant arrhythmias (KOP ET AL. 2004). 
 
T wave complexity. Other approaches in the assessment of regional repolarization 
inhomogeneity include principal component analysis of T wave morphology (PRIORI ET 
AL. 1997), descriptors of the 3-dimensional T loop (BATCHVAROV ET AL. 2000), singular 
value decomposition of the T wave (VAN HUYSDUYNEN ET AL. 2004) and parameters 






2.4 Congenital arrhythmogenic disorders  
2.4.1 Congenital long QT syndromes 
2.4.1.1 Pathophysiology and clinical characteristics 
The spectrum of congenital LQTS (formerly referred to as Romano-Ward syndrome, or 
when associated with congenital deafness, Jervell and Lange-Nielsen syndrome) 
encompasses a number of ion channel defects that produce alterations in cardiac ionic 
currents resulting in prolonged ventricular repolarization times. LQTS is characterized 
clinically by prolonged QT intervals and susceptibility to ventricular arrhythmias 
associated with syncopal spells, and potentially, sudden cardiac death.  
At least eight subtypes of LQTS have been described (LQT1-LQT8). Loss-of-function 
mutations in KCNQ1 and KCNE1 reduce IKs, forming the LQT1 (WANG ET AL. 1996a) 
and LQT5 (SPLAWSKI ET AL. 1997) subtypes of LQTS, respectively. Analogously, loss-
of-function mutations in KCNH2 (hERG) and KCNE2 reduce IKr, forming the LQT2 
(CURRAN ET AL. 1995) and LQT6 (ABBOTT ET AL. 1999) subtypes. Gain-of-function 
mutations in SCN5A cause defective inactivation of INa, forming the LQT3 subtype 
(WANG ET AL. 1996b). LQT4, arising from Ankyrin-B mutation, is the only subtype of 
LQTS recognized so far not caused by an ion channel defect (MOHLER ET AL. 2003). 
LQT7 (Andersen syndrome) and LQT8 (Timothy syndrome) are very rare multisystem 
disorders caused by defective inward rectifier potassium channel Kir2.1 (TRISTANI-
FIROUZI ET AL. 2002) and mutations causing amplified ICa(L) (SPLAWSKI ET AL. 2005, 
SICOURI ET AL. 2007), respectively. 
Arrhythmias tend to occur in different circumstances in the subtypes of LQTS 
(SCHWARTZ ET AL. 2001). In LQT1, symptoms are commonly associated with 
sympathetic activation at elevated HRs, such as during exercise and strong emotions. In 
LQT2 symptoms occur during arousal, startle or sudden exercise, whereas in LQT3 
symptoms typically occur during sleep. Swimming appears to be a genotype-specific 
trigger in LQT1 (MOSS ET AL. 1999), whereas auditory stimuli are specific triggers in 
LQT2 (WILDE ET AL. 1999).   
2.4.1.2 Electrophysiological characteristics 
APs and cellular basis of abnormal T waves. In experimental studies the most common 
LQTS subtypes have been modelled with selective pharmacologic blockade of ionic 
currents. The effects of such blockade on epicardial, endocardial and M cell APs and a 
transmural ECG have been extensively studied in arterially perfused canine left 
ventricular wedge preparations (YAN AND ANTZELEVITCH 1998, SHIMIZU AND 
ANTZELEVITCH 1998, SHIMIZU AND ANTZELEVITCH 2000). The LQT1 model prolonged 






in T wave morphology. In the LQT2 model, APs of M cells prolonged more than those of 
endo- or epicardial cells, increasing TDR and causing bifid T waves with prolonged TPE 
intervals. The LQT3 model prolonged phase 2 of the AP in all cell types, resulting in a 
markedly prolonged QT interval with a late onset T wave.  
 
QT intervals and morphology of the T wave. Prolonged QTc is by definition 
considered as one of the major diagnostic criteria of LQTS (SCHWARTZ ET AL. 1993). 
Nevertheless, a substantial overlap in QT duration has been reported between affected 
and unaffected relatives and many gene carriers have QTc intervals in the normal range 
(VINCENT ET AL. 1992, PIIPPO ET AL. 2001). Even carriers with normal QTc appear to be 
at risk for cardiac events, however (PIIPPO ET AL. 2001). Biphasic, notched or double-
peaked T waves are more frequently encountered in LQTS than in healthy controls 
(LEHMANN ET AL. 1994, MALFATTO ET AL. 1994), especially in the LQT2 genotype 
(LUPOGLAZOFF ET AL. 2001). Genotype-specific differences in T wave morphologies have 
been described (MOSS ET AL. 1995, ZHANG ET AL. 2000, STRUIJK ET AL. 2006), 
corresponding to the features observed in experimental LQTS models. It has been 
suggested that abnormal T wave morphology is a phenotypic expression of LQT2 and 
that its quantification could be useful in borderline diagnostic cases (COUDERC ET AL. 
2006). Moreover, Viitasalo et al. observed that the maximal amplitude ratio between late 
and early T wave peaks was independently associated with the occurrence of symptoms 
in both LQT1 and LQT2 patients (VIITASALO ET AL. 2006).  
 
TPE interval. The association between TdP and TDR observed experimentally 
suggests that a prolonged TPE interval in ECG may indicate arrhythmia risk in LQTS 
(SHIMIZU AND ANTZELEVITCH 1998, SHIMIZU AND ANTZELEVITCH 2000). Prolonged TPE 
has been reported in patients with both congenital (LUBINSKI ET AL. 1998, KHOSITSETH ET 
AL. 2003) and acquired LQTS (YAMAGUCHI ET AL. 2003). Furthermore, assessment of 
TPE from ambulatory ECG was shown to be useful in differentiating LQT1, LQT2 and 
unaffected subjects (VIITASALO ET AL. 2002b). TDR was shown to be greater in LQT2 
compared with LQT1, but LQT1 patients showed abrupt increases in TDR at elevated 
HRs (VIITASALO ET AL. 2002a).  
 
QT dispersion. Spatial dispersion of refractoriness (VASSALLO ET AL. 1988) and 
dispersion of MAP duration were shown to be increased in LQTS patients (BONATTI ET 
AL. 1983); therefore QT dispersion has been studied extensively in LQTS populations. A 
number of studies have reported more QT dispersion in LQTS patients than in healthy 
controls, both in non-genotyped (LINKER ET AL. 1992, PRIORI ET AL. 1994, LUBINSKI ET 
AL. 1998) and genotyped populations (SWAN ET AL. 1998a, MÖNNIG ET AL. 2001, INOUE 
ET AL. 2003). Inoue et al. reported that although dispersion of QTend intervals was 
similarly increased in LQT1 and LQT2 patients compared with controls, dispersion of 
QTpeak was increased only in LQT2 patients (INOUE ET AL. 2003). Some investigators 
have found a greater QT dispersion in symptomatic than in asymptomatic patients 
(MÖNNIG ET AL. 2001) whereas others have not (SWAN ET AL. 1998a, LINKER ET AL. 






ganglionectomy, and suggested that QT dispersion could predict the efficacy of 
antiadrenergic treatment (PRIORI ET AL. 1994). Increased QT dispersion has been reported 
to be associated with local wall motion abnormalities (mechanical dispersion) 
(NAKAYAMA ET AL. 1998) and the same group reported later that these abnormalities were 
related to inhomogeneities in myocardial sympathetic innervation (YAMANARI ET AL. 
2000). Increased spatial inhomogeneity of ventricular repolarization has been observed in 
LQTS also with BSPM (SHIMIZU ET AL. 1994) and MCG mapping (KANDORI ET AL. 
2002).  Both of these studies reported observations suggesting that repolarization times 
were longest over the LV. The concept of interventricular QT dispersion has not been 
assessed clinically, however.  
 
Rate adaptation of APD and QT intervals. In experimental LQTS models, rate 
adaptation of APD is steeper in LQT1, LQT2 and LQT3 than in normal preparations 
(PRIORI ET AL. 1996, SHIMIZU AND ANTZELEVITCH 1997, SHIMIZU AND ANTZELEVITCH 
1998) and steeper in LQT3 than in the other models. Transmural differences in rate-
dependency of APD (LITOVSKY AND ANTZELEVITCH 1989, ANTZELEVITCH ET AL. 1991) 
due to non-uniform expression of defective ion channels in epicardial, endocardial and M 
cells (SHIMIZU AND ANTZELEVITCH 2000) are likely to explain these differences. With one 
exception (LINKER ET AL. 1991), similar observations have been made in clinical studies: 
In ambulatory ECG recordings, LQTS patients had steeper QTpeak/RR slopes than 
controls (MERRI ET AL. 1992, EMORI ET AL. 1995). QTend/HR slopes during recovery 
after exercise were steeper in children with LQTS than in their healthy relatives (SWAN ET 
AL. 1998b). During face immersion testing QT/HR slopes were significantly steeper in 
children with LQTS than in controls (HIRAO ET AL. 1996). However, these studies 
comprised non-genotyped populations, and thus probably a mixture of the LQTS 
subtypes.     
More recent clinical studies on genotyped populations have also supported the 
previous experimental observations. In ambulatory ECG recordings LQT1 patients had 
steeper QTpeak/RR and QTend/RR slopes than controls at night, but not during the day 
(NEYROUD ET AL. 1998). In exercise testing, QT/HR slopes during exercise were steeper 
in LQT2 patients than both in LQT1 patients and controls, whereas during the recovery 
phase QT/HR slopes were steeper both in LQT1 and LQT2 than in controls (SWAN ET AL. 
1999a). Viitasalo et al. described genotype-specific patterns in the rate adaptation of QT 
intervals after cycle length grouping, allowing differentiation between LQT1 and LQT2 
patients with ambulatory ECG recordings (VIITASALO ET AL. 2002b). Observations from 
ambulatory recordings indicate that LQT2 and LQT3 patients exhibit steeper HR 
dependency of QT duration than LQT1 patients, with the former having longer QT 
intervals at slower but not at faster HRs (NĚMEC ET AL. 2004). Extramiana et al. reported 
that both QTpeak and QTend intervals were longer in LQT1 patients than controls at all 
measured HRs in ambulatory ECG (EXTRAMIANA ET AL. 2005). They demonstrated 
further that symptomatic LQT1 patients exhibited a lack of shortening of the late phase of 
the T wave in response to increasing HR, in contrast to asymptomatic patients and 






mental and physical stress testing between LQT1, LQT2 and controls (PAAVONEN ET AL. 
2001). 
 
QT interval variability. Temporal variability in the form of T wave alternans has been 
associated with LQTS (ZAREBA ET AL. 1994, KAUFMAN ET AL. 2001). Time-domain 
measures of QT interval variability calculated from ambulatory recordings were shown to 
be greater in LQTS patients than controls, despite similar HRV in both groups 
(PERKIÖMÄKI ET AL. 2002). LQT1 (except those with G589D mutation) and LQT2 
patients have shown an increased QT variability index compared with controls (BILCHICK 
ET AL. 2004). Furthermore, the spread of QT interval durations at a given HR has been 
shown to be larger in LQT2 and LQT3 than in LQT1 patients (NĚMEC ET AL. 2004). Thus, 
the QT interval exhibits temporal as well as spatial dispersion in LQTS physiology. 
2.4.1.3 Autonomic nervous system 
Autonomic innervation and activity. Scintigraphic studies have described local 
sympathetic dysinnervation in LQTS patients (GOHL ET AL. 1991, YAMANARI ET AL. 
2000). Moreover, Shamsuzzaman et al. reported a selective reduction of sympathetic 
nerve traffic to muscle blood vessels in LQTS patients, and they speculated that this may 
also be the case in the heart (SHAMSUZZAMAN ET AL. 2003). However, others have found 
quite normal scintigraphic patterns of cardiac sympathetic innervation in LQTS patients 
(CALKINS ET AL. 1993). Earlier studies have reported both higher (KATO AND YANAGAWA 
1994) and lower (MORITA ET AL. 1996) sympathetic activity in LQTS patients than in 
controls, when assessed by HRV indices. In a more recent study, however, no differences 
were found between LQT1, LQT2, LQT3 and controls in any of the parameters 
describing 24-hour HRV (PERKIÖMÄKI ET AL. 2002).        
 
Pharmacological autonomic interventions in experimental models. Shimizu and 
Antzelevitch described the role of ß-adrenergic agonists and antagonists under LQTS 
conditions in canine LV wedge preparations (SHIMIZU AND ANTZELEVITCH 2000). In the 
LQT1 model, isoprenaline prolonged APD of M cells, but abbreviated APD in epi- and 
endocardial cells, thereby increasing TDR markedly. Spontaneous or induced TdP 
occurred only in the presence of isoprenaline. This dramatic increase in TDR in response 
to ß-adrenergic stimulation and its association with arrhythmia explains the arrhythmia 
propensity during increased sympathetic activity in LQT1 patients. In the LQT2 model, 
isoprenaline increased TDR only transiently, due to an initial prolongation and 
subsequent abbreviation of M cell APD, but a persistent abbreviation of epicardial APD. 
In the LQT3 model, isoprenaline abbreviated APD in all myocardial layers, thereby 
causing a decrease in TDR. Isoprenaline transiently increased the incidence of TdP in 
LQT2 while it suppressed TdP in LQT3. All actions of isoprenaline were abolished in the 







Pharmacological autonomic interventions in patients. Studies conducted before the 
recognition of the genetic background of LQTS probably contained a mixture of different 
genotypes, making the results of many older studies difficult to interpret. The importance 
of sympathetic stimulation was noted in many of these early studies, however. Shimizu et 
al. reported that isoprenaline infusion and exercise prolonged the QTc interval in LQTS 
patients, but atrial pacing did not, indicating that sympathetic stimulation played an 
important role in generating the repolarization abnormalities in LQTS (SHIMIZU ET AL. 
1991a). Another study described QTc prolongation during isoprenaline, but not during 
exercise (KATAGIRI-KAWADE ET AL. 1995). It was further reported that isoprenaline 
increased both the duration and spatial dispersion of MAPs in LQTS patients, and 
induced early afterdepolarizations in some of them (SHIMIZU ET AL. 1991b). Similar 
effects on MAP duration and dispersion were described in response to adrenaline (HIRAO 
ET AL. 1996). Sun et al. studied symptomatic LQTS patients during steady-state 
adrenaline and phenylephrine infusions, both during sinus rhythm and atrial pacing (SUN 
ET AL. 1998). At constant paced HR, adrenaline prolonged the QTend interval and 
markedly increased QTend dispersion and QTpeak dispersion in LQTS patients but not in 
controls. Phenylephrine did not modulate QT duration or dispersion. Aizawa et al. 
described, in a study of only five LQTS patients, prolongation of QTc during 
intracoronary administration of acetylcholine; inducing TdP in two of the patients 
(AIZAWA ET AL. 1996).   
Genotype-specific responses to adrenergic agonists have subsequently been described, 
proving similar to those expected from the experimental models. In a landmark clinical 
study, Tanabe et al. recorded BSPM in LQT1, LQT2 and controls before and after a 
continuous adrenaline infusion (TANABE ET AL. 2001). Adrenaline significantly prolonged 
the rate-corrected QTend and TPE intervals but not the QTpeak interval in both LQT1 
and LQT2 patients. In addition, rate-corrected QTend dispersion but not QTpeak 
dispersion increased in both patient groups. All adrenaline-induced changes were of 
greater magnitude in LQT1 than LQT2, suggesting that LQT1 patients are more sensitive 
to sympathetic stimulation. Noda et al. studied the effects of a bolus injection of 
adrenaline, followed by a continuous steady-state infusion (“Shimizu protocol”) in LQT1, 
LQT2 and LQT3 patients (NODA ET AL. 2002). In LQT1 patients, the QTc interval 
prolonged markedly in response to the bolus and remained prolonged during continuous 
infusion. LQT2 patients showed dramatic prolongation of QTc after the bolus, but QTc 
shortened to baseline level during steady-state infusion. The responses of LQT3 patients 
did not differ significantly from controls, showing only small increases in QTc during the 
bolus. Ackerman et al., on the other hand, reported that adrenaline infusion in gradually 
increasing doses (“Mayo protocol”) prolonged the uncorrected QT interval only in LQT1 
patients, but not in LQT2, LQT3 or controls (ACKERMAN ET AL. 2002), referring to it as a 
paradoxical QT response. They reported in a subsequent larger study that a paradoxical 
QT response, when defined as a QT prolongation of ≥30 ms during low-dose adrenaline 
infusion, had 93% sensitivity and 86% specificity for LQT1 status (VYAS ET AL. 2006). 
The paradoxical QT response identified even concealed LQT1 (genotype-positive patients 
with unequivocal QTc) with high accuracy. Similar observations were made in a study by 






protocol” prolonged rate-corrected QTpeak, QTend and TPE duration and increased 
QTpeak dispersion also in asymptomatic LQT1 mutation carriers with only borderline 
resting QTc. In an invasive study, adrenaline infusion was shown to prolong phase 3 of 
RV MAPs and to increase the rate dependence of MAP durations in symptomatic LQT1 
patients, but not in LQT2 patients or controls (VIITASALO ET AL. 2005). Adrenaline 
infusion has also been observed to precipitate genotype-specific T wave abnormalities 
(KHOSITSETH ET AL. 2005) and to accentuate the beat-to-beat variability of QT intervals in 
LQT1 patients (SATOMI ET AL. 2005).  
Phenylephrine-induced bradycardia has been reported to shorten the TPE interval in 
symptomatic LQT1 patients but to prolong it in symptomatic LQT2 patients (KHOSITSETH 
ET AL. 2003). Kaufman et al. found no difference in the QT responses to an intravenous 
phenylephrine bolus between LQT1, LQT2 and control subjects, whereas during 
adrenaline infusion a cut-off QTc-value of 600 ms distinguished LQT1 patients from 
controls with 80% sensitivity and 80% specificity (KAUFMAN ET AL. 2005). Nĕmec et al. 
observed that phenylephrine and dobutamine infusion caused nonalternating beat-to-beat 
T wave lability in LQT1, LQT2 and LQT3 patients (NĔMEC ET AL. 2003). 
Combined, these previous reports underscore the importance of sympathetic 
stimulation particularly in LQT1 subtype of LQTS, providing clinical evidence in support 
of the previous experimental findings. They also suggest that sympathetic challenge may 
be used as a diagnostic test especially among suspected LQT1 carriers exhibiting normal 
QT intervals. 
  
Physical exercise. Exercise was observed to induce QTc-prolongation in LQTS 
patients but not in controls (SHIMIZU ET AL. 1991a, VINCENT ET AL. 1991). In contrast, 
Krahn with colleagues reported that the rate corrected R wave peak to T wave peak 
interval shortened to a greater extent in LQTS patients than in controls during exercise 
(KRAHN ET AL. 1997). They also described a persistent shortening of this interval during 
recovery in LQTS, which caused a hysteresis loop of the RT/RR relationship in almost all 
LQTS patients but only in a few of the controls. Treatment with ß-blockers reduced this 
hysteresis (KRAHN ET AL. 2002). Swan et al. measured QTpeak and QTend intervals at 
similar HRs during and after exercise in children with LQTS and their healthy relatives 
(SWAN ET AL. 1998b). In control subjects, both QTpeak and QTend intervals were 
significantly shorter during recovery than it was during exercise at the same HR. In 
contrast, LQTS patients exhibited abnormal lengthening of QTend during recovery. The 
varying results of these previous studies may perhaps be explained by the confounding 
effects of mixed LQTS populations, the inappropriate rate correction of QT intervals and 
differing exercise protocols. It has been shown that in LQTS patients, sudden intense 
exercise induces more pronounced repolarization abnormalities and steeper QT-HR 
relations than observed during graded exercise (CHAUHAN ET AL. 2004, WALKER ET AL. 
2005).     
Swan et al. compared the QT and HR responses to exercise in the two most common 
genotypes of LQTS (LQT1 and LQT2) (SWAN ET AL. 1999a). LQT1 was associated with 
a diminished chronotropic response to exercise and exaggerated prolongation of QT 






interval during exercise than LQT1 patients. In a similar study, significant prolongation of 
QTc and rate-corrected TPE at peak exercise was observed in LQT1 but not in LQT2 
patients (TAKENAKA ET AL. 2003).  
 
Cardiovascular autonomic function tests. A case report first described that adrenergic 
stimulation by Valsalva manoeuvre and cold pressor testing precipitated ventricular 
bigeminy in a patient with LQTS (RUBIN ET AL. 1979). A later clinical study reported 
QTc interval prolongation in response to the Valsalva manoeuvre in LQTS patients 
(MITSUTAKE ET AL. 1981). This prolongation was particularly pronounced in patients with 
frequent symptoms and was associated with T wave alternans and short runs of 
ventricular tachycardia in one of them. These repolarization abnormalities were 
suppressed by propranolol, and the authors suggested that the Valsalva manoeuvre might 
be useful in evaluating both arrhythmia risk and efficacy of treatment in LQTS. Another 
study described longer QTc in LQTS compared with controls during cold pressor testing 
and Valsalva manoeuvre, but the QTc values during the tests were not significantly 
different compared with baseline values in either group, however (EGGELING ET AL. 
1992). Effects of the Valsalva manoeuvre have not been studied in genotyped 
populations. 
In LQTS patients, QTc prolongation has been described both during the HR 
acceleration (KATAGIRI-KAWADE ET AL. 1995) and HR deceleration phases (YOSHINAGA 
ET AL. 1999) of face immersion in cold water. It was observed in a small study that 
treatment with propranolol or mexiletine attenuated the prolongations of QTc and TPE 
induced by face immersion (HARAGUCHI ET AL. 2005).  
Paavonen et al. compared the QT interval adaptation to mental and physical stress at 
similar HRs in asymptomatic LQT1 patients, LQT2 patients and controls (PAAVONEN ET 
AL. 2001). In controls, QT interval shortening was more pronounced during exercise than 
during mental stress at comparable HR, whereas no such difference was seen in either 
LQT1 or LQT2 patients. QT interval responses to the interventions did not differ between 
LQT1 and LQT2 patients.  
2.4.2 Arrhythmogenic right ventricular dysplasia 
Arrhythmogenic right ventricular dysplasia (ARVD) is a familial cardiomyopathy 
associated with potentially life-threatening arrhythmia of RV origin, involving diffuse or 
segmental loss of RV myocardium and replacement with fibrofatty tissue (MARCUS ET AL. 
1982, THIENE ET AL. 1988). Many of the thus far identified causative mutations reside in 
genes encoding for key components of desmosomes (SEN-CHOWDHRY ET AL. 2005), 
which are scaffolding proteins involved in cell-to-cell adhesion. Consequent defective 
mechanical coupling between cells may result in gap junction remodelling, accounting for 
the increased arrhythmia propensity. After an initial “concealed” phase, ARVD has been 
thought to progress from localized to a more global RV dysfunction, ultimately followed 
by LV involvement and biventricular failure (SEN-CHOWDHRY ET AL. 2005). More 






use of the broader term “arrhythmogenic cardiomyopathy” (SEN-CHOWDHRY ET AL. 
2007). 
Diagnosis of ARVD relies on a set of major and minor criteria encompassing 
structural, histological, ECG, arrhythmic and genetic features, as proposed by an 
international working group (MCKENNA ET AL. 1994). Major criteria include severe RV 
dysfunction or dilatation, fibrofatty replacement of RV myocardium, local conduction 
abnormalities and family history confirmed by autopsy or surgery. Minor criteria include 
mild RV dysfunction or dilatation, inverted T waves in leads V2-V3, late potentials on 
signal-averaged ECG, ventricular tachycardia or frequent premature beats (>1000/24 
hours) of RV origin, and family history of ARVD. The presence of 2 major criteria, or 1 
major + 2 minor criteria, or 4 minor criteria are required for diagnosis of ARVD.   
 
ECG abnormalities. Among the international diagnostic criteria, epsilon waves and QRS 
duration >110 ms in leads V1-V3 (in the absence of right bundle branch block) are 
considered major criteria whereas the occurrence of inverted T waves in leads V2-V3 is 
considered a minor criterion (MCKENNA ET AL. 1994). ECG manifestations of ARVD 
mostly involve abnormalities of the QRS complex (METZGER ET AL. 1993, KINOSHITA ET 
AL. 1995, KAZMIERCZAK ET AL. 1998, PETERS ET AL. 2007), and a prolonged S wave 
upstroke has been reported to be the most frequent ECG abnormality (NASIR ET AL. 
2004). Endocardial electroanatomic mapping has shown that the dysplastic regions of the 
RV exhibit discrete areas of low amplitude electrograms (BOULOS ET AL. 2001). ARVD 
patients exhibit abnormal QRST integral maps indicative of delayed RV repolarization in 
BSPM (PEETERS ET AL. 1997, DE AMBROGGI ET AL. 1997). In addition, principal 
component analysis of the T wave was reported to detect repolarization abnormalities not 
apparent in QRST integrals or 12-lead ECG (DE AMBROGGI ET AL. 1997). ARVD patients 
have more QT dispersion than control subjects (BENN ET AL. 1999, FAGUNDES ET AL. 
2000, TURRINI ET AL. 2001). One study reported normal QT dispersion, however, but 
noted prolonged QTc intervals (>440 ms) in half of the studied ARVD patients 
(KAZMIERCZAK ET AL. 1998). Turrini with colleagues reported that QT dispersion was the 
strongest independent predictive marker of sudden death in ARVD patients (TURRINI ET 
AL. 2001). They further noted that the maximum QT intervals were found in the right 
precordial leads. 
  
Autonomic nervous system. ARVD patients have abnormal cardiac sympathetic 
innervation as determined by scintigraphic methods (LERCH ET AL. 1993, WICHTER ET AL. 
1994, WICHTER ET AL. 2000). Moreover, ARVD patients have decreased HRV that 
appears to correlate with the extent of the disease (FOLINO ET AL. 2002). Symptoms are 
usually associated with physical or mental stress, and it has been shown that the 
arrhythmias can be induced by isoproterenol infusion (HAISSAGUERRE ET AL. 1990) and 
suppressed by drugs with antiadrenergic properties (WICHTER ET AL. 1992). These 
findings indicate that the activity of the autonomic nervous system may contribute to the 






2.4.3 Brugada syndrome 
The Brugada syndrome (BRUGADA AND BRUGADA 1992) is characterized by marked ST-
elevation in the right precordial ECG leads and a high incidence of sudden arrhythmic 
death. Loss-of-function SCN5A mutations are associated with this disorder, causing 
attenuated INa (CHEN ET AL. 1998) as opposed to the augmented INa observed in LQT3. 
Reduced INa causes partial or complete loss of the AP dome during phase 2 in RV 
epicardium where Ito is prominent, but not in endocardium where Ito is weak. This gives 
rise to a transmural voltage gradient that explains the ST elevation observed in ECG leads 
placed over the RV (YAN AND ANTZELEVITCH 1999, KURITA ET AL. 2002) and creates a 
substrate for re-entry (ANTZELEVITCH 2001). Consequently, sodium channel blockers are 
valuable in the diagnosis of the disease, by unmasking the abnormal ECG pattern (HONG 
ET AL. 2004). Recently, loss-of-function mutations of ICa(L) have also been found to cause 
the Brugada phenotype (ANTZELEVITCH ET AL. 2007). 
In Brugada patients, QTc intervals are generally not prolonged in any other leads than 
V1-V3 (where the ST-elevation hampers QT measurements). However, TPE duration, 
TPE dispersion and the presence of prolonged QTc in lead V2 have been shown to 
correlate with arrhythmic events (CASTRO HEVIA ET AL. 2006). QT dispersion (IKEDA ET 
AL. 2001, NANKE ET AL. 2002) and T wave alternans (IKEDA ET AL. 2001) has been 
reported not to be significantly different between Brugada patients and healthy controls. 
BSPM mapping has shown depolarization and repolarization abnormalities especially 
over the RV outflow tract (HISAMATSU ET AL. 2004). Decreased QTpeak/RR and 
QTend/RR slopes and impaired QT prolongation in response to slowing of HR have been 
described in patients with Brugada-like ECG and a history of idiopathic ventricular 
fibrillation (FUJIKI ET AL. 2004).  
Scintigraphic findings indicative of presynaptic myocardial sympathetic dysfunction 
have been reported (WICHTER ET AL. 2002). Higher vagal and lower sympathetic activity 
in symptomatic Brugada patients than in controls was suggested from HRV observations 
(NAKAZAWA ET AL. 2003). The ST elevation in Brugada syndrome is augmented by α-
adrenergic stimulation, but is attenuated by ß-adrenergic stimulation (MIYAZAKI ET AL. 
1996). These previous findings indicate that although the arrhythmogenic substrate is 
related to local repolarization abnormalities, sympathetic stimulation appears not to be an 
important precipitator of arrhythmic events in the Brugada syndrome. 
2.4.4 Catecholaminergic polymorphic ventricular tachycardia 
Familial polymorphic ventricular tachycardia is characterized by salvos of bidirectional 
and polymorphic ventricular tachycardias, occurring typically during adrenergic 
stimulation or intense physical exercise (LEENHARDT ET AL. 1995, SWAN ET AL. 1999b). 
The incidence of sudden cardiac death at early age is very high. Mutations in the cardiac 
ryanodine receptor gene (LAITINEN ET AL. 2001, PRIORI ET AL. 2001) or the calsequestrin 
2 gene (LAHAT ET AL. 2001) resulting in abnormal intracellular calcium handling have 
been identified as causes for the disorder. QTc intervals of the patient populations studied 






AL. 1999b). In a canine LV wedge model of this syndrome, it was observed that the 
epicardium was a frequent source of ectopic beats during sympathetic stimulation (NAM 
ET AL. 2005). The reversed activation sequence of epicardial ectopic beats markedly 
amplified TDR, thus providing a substrate for arrhythmia. 
2.4.5 Hypertrophic cardiomyopathy 
Hypertrophic cardiomyopathy is a familial cardiac disease with an autosomal-dominant 
pattern of inheritance, presenting clinically with LV hypertrophy. A vast number of 
different mutations have been identified (FUNG ET AL. 1999). It has been recognized as 
one of the most common causes of sudden death in otherwise healthy young individuals, 
thought to be caused by ventricular arrhythmias in most cases. 
Repolarization abnormalities (e.g., prolonged QTc intervals, increased QT dispersion 
and increased complexity of T waves) are frequently described in these patients (ZAIDI ET 
AL. 1996, SAVELIEVA ET AL. 1998a, YI ET AL. 1998, JOUVEN ET AL. 2002, BARLETTA ET 
AL. 2004). No differences in QT/RR slopes or QT dispersion responses were observed 
between patients and healthy controls during exercise testing (YI ET AL. 2000). However, 
increased QT variability has been noted in patients with hypertrophic cardiomyopathy, 
particularly in those with history of syncope, suggesting that an altered control of 
repolarization could be related to arrhythmia in this disorder (CUOMO ET AL. 2004). 
Scintigraphic studies have suggested impaired sympathetic cardiac innervation 
(LEFROY ET AL. 1993, SCHAFERS ET AL. 1998).  HRV studies have shown both decreased 
sympathetic regulation (FEI ET AL. 1995, LIMBRUNO ET AL. 1998) as well as decreased 
parasympathetic regulation (MORNER ET AL. 2005). Also, selective impairments of the HR 
responses to deep breathing and Valsalva have been reported, indicating impaired 






3. Aims of the study 
The studies reported in this thesis were designed to investigate the effects of standardized 
cardiovascular autonomic function tests on body surface measurements of ventricular 
repolarization and its homogeneity, especially in patients prone to ventricular arrhythmias 
associated with sudden changes in autonomic activity. The specific aims of the substudies 
were: 
 
1. To outline the effects of abrupt changes in autonomic activity on QT intervals and 
spatial QT dispersion in healthy patients. 
 
2. To examine the dynamics of QT intervals and spatial QT dispersion in the 
multichannel MCG in healthy patients. 
 
3. To explore the effects of standardized cardiovascular autonomic function tests on QT 
intervals in patients with LQT1 subtype of LQTS. 
 
4. To study the effects of the cardiovascular autonomic function tests on interventricular 
ECG dispersion of repolarization in LQT1 patients. 
 
5. To explore the effects of cardiovascular autonomic function tests on ECG ventricular 






4. Patients and methods 
4.1 Study patients 
Studies I-II: Ten healthy male volunteers (age 27 ± 6 years) without history or signs of 
cardiovascular disorders participated. They were all non-smokers, had a normal 12-lead 
ECG and took no medications.  
  
Studies III-IV: Nine LQT1 patients (age 41 ± 12, seven women) coming from eight 
different families were studied. All of them carried the same missense C-terminal 
KCNQ1 mutation (G589D), a common founder mutation in Finland (PIIPPO ET AL. 2001). 
They were all asymptomatic, but everyone had at least one symptomatic family member. 
Eight healthy control subjects (age 44 ± 10, six women) served as controls. None of the 
patients or healthy control subjects took any medications. They had no signs of coronary 
artery disease on exercise testing or structural heart disease on cardiac magnetic 
resonance imaging. On baseline ECG, the asymptomatic LQT1 patients had normal T 
wave morphology and normal or only mildly prolonged QTc intervals (mean 445 ± 21 
ms, range 407–469 ms). All control subjects had normal QTc intervals (mean 405 ± 21 
ms, range 375–432 ms).  
  
Study V: Nine unrelated patients with ARVD (age 53 ± 7, five women) were recruited 
from a national database. Patients had to fulfil the international diagnostic criteria 
(MCKENNA ET AL. 1994) and not to have complete right bundle branch block, pacemaker 
or a cardioverter-defibrillator. All ARVD patients had structural abnormalities of the RV 
but normal LV function on echocardiography, magnetic resonance imaging or cine-
angiography. They all had a history of arrhythmic symptoms and documented arrhythmia 
of RV origin, and sustained ventricular arrhythmia was induced during 
electrophysiological study in all patients. Therefore, their medications were not 
discontinued: 7 ARVD patients were on ß-antiadrenergic drugs (sotalol in two cases) and 
one patient was on amiodarone. Nine healthy volunteers served as controls (age 44 ± 10, 
six women). All of them had normal exercise tests and cardiac magnetic resonance 
imaging. 
 
In all studies, patients and control subjects refrained from coffee, tea and cola drinks, 
and heavy meals for 6 hours, and alcohol and extreme physical activity for 24 hours 
before the study. 
4.2 Cardiovascular autonomic function tests 
In studies I and II, the subjects underwent a series of cardiovascular autonomic function 







1. Quiet breathing: Breathing frequency was cued with a metronome at 12 
cycles/minute. 
2. Mental stress: A verbal mental arithmetic test with serial subtraction of 13 
or 17 from a four-digit number, with loud metronome beeps at 120/min 
used as a distraction. 
3. Valsalva manoeuvre: An expiration pressure of 40 mmHg, determined 
with an aneroid manometer, was sustained for 15 seconds.  
4. Sustained handgrip: Squeezing of a dynamometer at 30% of 
predetermined maximal handgrip strength, for five minutes or until 
fatigue. Breathing frequency was cued at 12 cycles/minute to avoid 
performing a Valsalva-strain. 
5. Deep breathing: Breathing at maximal tidal volume, 6 breathing 
cycles/minute. 
6. Hyperventilation: Deep breathing was continued for five minutes, to cause 
acute respiratory alkalosis. 
7. Cold pressor test: Immersion of the left hand in +4° C iced water for two 
minutes. Breathing was cued at 12 cycles/minute. 
 
In studies III-V, the function test series was slightly different: 
 
1. Quiet breathing: Baseline measurement for 5 minutes during spontaneous 
quiet breathing 
2. Deep breathing: 4 deep breaths to subjective maximal vital capacity, with 
expiration and inspiration cued at 6 seconds each 
3. Valsalva manoeuvre: An expiration pressure of 40 mmHg, determined 
with an aneroid manometer, was sustained for 15 seconds. 
4. Mental stress: A verbal mental arithmetic test with serial subtraction of 13 
or 17 from a four-digit number for 3 minutes. The subjects were 
periodically urged to count faster. 
5. Sustained handgrip: Squeezing of a dynamometer at 30% of 
predetermined maximal handgrip strength, for 3 minutes. Care was taken 
to avoid a Valsalva manoeuvre. 
6. Supine bicycle exercise: A 10-minute supine exercise test. 
 
A 1-minute baseline recording preceded each test, and recovery was monitored for 1 
minute, except for 10 minutes after exercise. There was sufficient rest between each test 
to allow for stabilization of basic physiologic state.  
4.3 Signal acquisition 








Studies I-II: Breathing phase was monitored measuring air pressure changes in a tube 
placed around the caudal part of the thorax. All leads of a standard 12-lead ECG were 
recorded simultaneously. In Study II, MCG was recorded with a 67-channel 
cardiomagnetometer (Neuromag Ltd., Helsinki, Finland), consisting of 7 co-axial and 60 
planar dc-SQUID (Superconducting QUantum Interference Device) gradiometers 
arranged in a hexagonal pattern, immersed in liquid helium inside a cylindrical dewar. 
The surface of the dewar (diameter 30 cm) was positioned 15 cm caudally from the 
jugular notch and 5 cm to the left, as close to the patient’s chest as possible. All signals 
were band-pass filtered at 0.03-100 Hz and analog-to-digital converted at 1000 Hz. Both 
the planar (unit pT/cm) and the axial (unit pT) MCG signals were converted off-line to 33 
co-axial signals (unit pT) with an interpolation method based on mathematical modelling 
of the source current distribution (NUMMINEN ET AL. 1995), allowing for better direct 
comparison between ECG and MCG. 
  
 
Studies III-V: BSPM was recorded with three limb leads and 25 unipolar chest leads. 
Adhesive flexible plastic strips with Ag/AgCl electrodes at 5 cm intervals were placed on 
the anterior chest, from the right parasternal area to the left anterior axillary line (Figure 
3). The simultaneously recorded signals were band-pass filtered at 0.03-300 Hz and 
analog-to-digital converted at 1000 Hz. 
 






4.4 Signal processing and QT interval measurements 
Studies I-II: QT measurements were performed on manually selected single beats. The 
effect of breathing phase was explored by selecting beats from end-inspiration and end-
expiration during quiet and deep breathing. Otherwise, representative beats at fixed time 
intervals (at end-expiration) as well as at HR extremes were selected. 
For a given beat, earliest QRS onset in any channel was identified and this same QRS 
onset was used in all channels. The intervals from QRS onset to the end and to the peak 
of the T wave (QTend and QTpeak, respectively) were determined with an automatic 
computer-based method. First, a baseline was identified within user-defined limits in the 
T-P interval; with linear interpolation between two successive intervals in case of baseline 
drift. A second-degree polynom was then fitted on the T wave. T wave peak was defined 
as the point where the first numerical derivative reached zero, and T wave end was 
defined as the intersection of the maximum slope tangent and the baseline. In more 
complex T waves, the second derivative of the signal was used to detect discontinuities 
after the T wave apex (OIKARINEN ET AL. 1998), and U waves were excluded according to 
the principles outlined by Lepeschkin and Surawicz (LEPESCHKIN AND SURAWICZ 1952). 
Channels with excessive noise, low-amplitude T waves (< 20 µV or 600 fT) or clearly 
misinterpreted time points for other reasons (e.g., unclear baseline, indeterminate T wave 
apex, biphasic T wave), were excluded.  
 
Studies III-V: Signals were triggered to the steepest upward slope of the R wave on a 
high-amplitude ECG channel. A fitted spline baseline was subtracted to negate baseline 
drift. Noise levels were reduced with continuous averaging over five successive QRS 
complexes, except during deep breathing and Valsalva where changes in HR and QT 
intervals were expected to be more rapid. The trigger point (i.e., start of the R wave) 
rather than Q wave was used as reference point in beat-to-beat QT measurements, as this 
approach is less sensitive to measurement errors caused by noise due to movement during 
the interventions. QTpeak and QTend were then automatically determined for every heart 
beat with a modification of the algorithm used in Studies I and II. An example of the beat-
to-beat measurements plotted against time is presented in Figure 4a. Noisy channels and 
clearly misinterpreted intervals were manually excluded. Excessive noise precluded 
reliable QT interval measurements during supine exercise, therefore only the recovery 
phase was analysed.  
4.5 Definitions and statistical analyses  
Study I: Instantaneous HR was generally calculated from 3 successive R-R intervals. 
When comparing breathing phases only the previous R-R interval was used. The mean 
QTpeak and QTend values of all accepted leads were calculated and defined as global 
QTpeak and QTend intervals, respectively. Spatial QT dispersion was defined as the 






intervals was also explored by calculating the standard deviation of the measured QT 
intervals.  
 
Study II: HR and global QTpeak and QTend intervals and their dispersion were 
measured as in Study I. However, the MCG channels with the longest and the shortest QT 
interval were omitted before QT dispersion assessment in order to reduce the effects of 
outliers. In addition, the TPE interval was measured as QTend - QTpeak and TPE 
dispersion as maximum TPE - minimum TPE. 
  
Study III: HR extremes and global QTpeak and QTend intervals were defined as in 
Studies I and II. The mean TPE over all channels was defined as the global TPE interval. 
QTc values were calculated for the 5-minute resting period only, otherwise only the 
measured intervals were used.  
Averages over defined time periods were calculated to facilitate statistical 
comparisons of the beat-to-beat recordings: 5- and 10-second periods during Valsalva, 
and 30-second periods during mental stress, handgrip and recovery from exercise. Using 
these time periods, changes compared with baseline values were calculated (∆HR, 
∆QTpeak, ∆QTend and ∆TPE) and explored by plotting them against time (Figure 4b). 
Changes in the time intervals were also plotted against ∆HR (Figure 4c). 
Beat-to-beat QT interval adaptation to HR change was assessed by plotting global 
QTpeak and QTend intervals against the preceding R-R interval and instantaneous HR 
(Figure 4d). Slopes of the linear regression lines and correlation coefficients were 
computed for comparisons between study groups. QT/HR relationships were also studied 
by plotting the averaged QT interval and HR values over the defined time periods. 
Deep breathing difference was calculated as the mean difference between maximum 
HR during inspiration and minimum HR during expiration. From the HR responses to the 
Valsalva manoeuvre, the Valsalva ratio (longest R-R interval shortly after strain/shortest 
R-R interval during strain) and the tachycardia ratio (shortest R-R interval during 







Figure 4. Demonstration of the methods used for QT interval analyses in Studies III-V, using 
data from an unaffected healthy subject during mental stress testing: a) QTend 
interval plotted against time, b) change in QTend interval (∆QTend) plotted against 
time, c) ∆QTend plotted against change in heart rate (∆HR) and d) QTend interval 
plotted against instantaneous heart rate (HR), with regression line.  
Studies IV-V: HR and global QT intervals were measured and time periods defined as 
in study III. QTc values were determined for the 5-minute resting period only. ECG leads 
were further grouped in LV type and RV type leads, according to QRS morphology. 
Leads showing QRS complexes with R wave amplitude of more than 2/3 of total QRS 
amplitude were classified as LV leads whereas those with R wave amplitude of less than 
1/3 of total QRS amplitude were classified as RV leads. All measured intervals were then 
averaged for LV and RV leads separately, using the defined time periods. As an index of 
interventricular dispersion of repolarization, intervals measured from RV were subtracted 
from corresponding intervals measured from LV, and defined as interventricular QTpeak, 
QTend and TPE dispersion, respectively. 
 
Reproducibility of QT measurements. The reproducibility of the QT interval and QT 
dispersion measurements in studies I and II was tested by repeating the procedure on a 
sample of ECGs from the Valsalva and deep breathing tests (778 beats): The mean 






0.1%, whereas it ranged from 0.5% to 0.8% for the QT dispersion indices. For the method 
of beat-to-beat measurement of global QTpeak and QTend intervals, the coefficient of 
variation had been determined as 0.8% and 0.6%, respectively, in earlier resting 
measurements (HEKKALA ET AL. 2006). 
 
Statistics. Continuous values were presented as mean ± SD, except in the figures of 
studies III-V where mean ± SEM was used. Parametric tests were used for data having a 
normal distribution (assessed with the Kolmogorov-Smirnov test), otherwise 
nonparametric tests were used. In Studies I and II, analysis of variance for repeated 
measurements, the Friedman test or the paired t-test was used when comparing changes 
between different phases during autonomic testing. In Studies III-V, between-group 
comparisons were made with Student's t-test or Mann-Whitney U-test. Within-group 
changes from baseline were assessed with the paired t-test or Wilcoxon signed rank test. 
Pearson’s or Spearman’s correlation coefficients (R) were used to test the strength of the 
linear relationship between continuous variables. A two-tailed P value < 0.05 was 







5. Results of the studies 
5.1 Heart rate responses 
Single-beat studies (I-II). Significant (P < 0.001) HR increases occurred during all 
autonomic function tests: The maximum HRs reached were 103 ± 14 bpm during 
Valsalva, 100 ± 16 bpm during mental stress, 73 ± 7 bpm during sustained handgrip, 75 ± 
8 bpm during hyperventilation and 77 ± 12 bpm during the cold pressor test. 
 
LQT1 patients (III-IV). Resting HR was 62 ± 5 bpm in the LQT1 group and 64 ± 10 
bpm in the control group (P = NS). HR increased significantly (P < 0.001) during all tests 
in both study groups. LQT1 patients showed smaller HR increases than control subjects in 
response to the Valsalva manoeuvre, mental stress, and sustained handgrip, whereas the 
HR deceleration after the Valsalva strain and the deep breathing difference were similar 
(Figure 5). There were no significant differences in the Valsalva or tachycardia ratios 
(1.71 ± 0.29 vs. 1.77 ± 0.25, P = 0.35 and 0.65 ± 0.09 vs. 0.60 ± 0.09, P = 0.12) between 
LQT1 patients and controls. In a maximal bicycle exercise test performed as a part of the 
screening process before the study, the maximum HRs were 160 ± 11 bpm in LQT1 
patients and 180 ± 8 bpm in controls (P < 0.001). 
 
ARVD patients (V). Resting HR was 58 ± 15 bpm in ARVD patients and 64 ± 9 bpm 
in controls (P = NS). In ARVD patients HR increased to a maximum of 78 ± 23 bpm 
during Valsalva, 70 ± 20 bpm during mental stress and 65 ± 19 bpm during handgrip (P < 
0.01 compared to baseline for all). In controls the corresponding maximum HRs reached 
were 95 ± 14 bpm, 88 ± 9 bpm and 79 ± 13 bpm, respectively (P < 0.001 compared to 
baseline). At cessation of exercise, HR was 105 ± 22 bpm in ARVD patients and 112 ± 9 
bpm in controls. ARVD patients had smaller deep breathing difference than controls (9 ± 
4 vs. 18 ± 5 beats, P = 0.002). In response to the Valsalva manoeuvre, ARVD patients had 
slightly higher tachycardia ratios than controls (0.73 ± 0.10 vs. 0.61 ± 0.08, P = 0.01), 
whereas the Valsalva- and bradycardia ratios were not significantly different (1.58 ± 0.34 







Figure 5. Maximum changes in heart rate (∆HR) during the tachycardia (max) and 
bradycardia (min) phases of the Valsalva manoeuvre, mental stress and sustained 
handgrip in LQT1 patients (closed bars) and controls (open bars). DBD = deep 
breathing difference. * P < 0.05 and *** P < 0.001 LQT1 vs. controls (Study III). 
5.2 QT intervals 
Single-beat studies (I-II). ECG QTpeak intervals shortened significantly (P < 0.01) during 
the autonomic tests: from 315 ± 22 to 293 ± 16 ms during Valsalva, from 301 ± 23 to 280 
± 29 ms during mental stress, from 310 ± 20 to 290 ± 20 ms during sustained handgrip, 
from 315 ± 24 to 299 ± 21 ms during cold pressor testing, and from 311 ± 22 to 291 ± 21 
ms during hyperventilation. Corresponding QTend changes were from 388 ± 22 to 366 ± 
15 ms, from 374 ± 24 to 351 ± 28 ms, from 383 ± 23 to 358 ± 23 ms, from 386 ± 27 to 
370 ± 22 ms, and from 383 ± 25 to 356 ± 24, respectively (P < 0.01 for all). Quiet 
breathing did not change the QT intervals significantly when comparing end-expiration 
with end-inspiration in ECG and MCG measurements. During deep breathing, however, 
QTpeak and QTend intervals were longer during expiration compared with inspiration 
(Table 4). MCG recordings showed on average slightly longer QT intervals than ECG, 
but ECG and MCG measurements showed a close correlation during the autonomic tests 












Table 4. Effects of deep breathing phase on QT intervals in ECG and MCG recordings 
(Studies I-II). 
 Inspiration ECG Expiration ECG Inspiration MCG Expiration MCG 
R-R interval 795 ± 118 1047 ± 151***   
QTpeak 305 ± 19 311 ± 24 305 ± 24 316 ± 23** 
QTend 375 ± 21  383 ± 26* 380 ± 26 393 ± 27** 




LQT1 patients (III-IV). QTend intervals shortened less in LQT1 patients than in 
controls during the autonomic tests (Figure 6). Plotting ∆QTend against ∆HR shows the 
changes in QTend relative to the changes in HR, forming a loop during the autonomic 
tests and a line during the recovery phase of supine exercise (Figure 7). Valsalva 
manoeuvre induced the widest loops in both study groups. LQT1 patients showed smaller 
loops than controls during mental stress and handgrip. 
In the recovery phases of the tests, LQT1 patients showed an overshoot of QTend 
intervals to longer values than they were at baseline (Figures 6 and 7). The number of 
tests with such an overshoot was 2.4 ± 1.7 in LQT1 patients and 0.8 ± 0.7 in controls (P = 
0.02), with the most distinctive overshoot occurring in response to the Valsalva 
manoeuvre. 
QTend/HR slopes were steeper in LQT1 patients than in controls during deep 
breathing, Valsalva and sustained handgrip (Table 5). QT rate adaptation during recovery 
of exercise was biphasic, which prevented the assessment of linear slopes. However, at 1 
minute after exercise, QTend values had already recovered to 91 ± 5% of baseline value 
in LQT1 patients compared with only 82 ± 5% in controls (P = 0.005). 
 
 
Table 5. QTend/HR slopes during autonomic tests in LQT1 patients and controls. 
 LQT1 Controls 
Deep breathing  -1.17 ± 0.45* -0.71 ± 0.37 
Valsalva  -0.74 ± 0.33* -0.47 ± 0.20 
Mental stress -0.84 ± 0.58 -0.73 ± 0.26 
Handgrip  -1.15 ± 0.46*  -0.67 ± 0.38 







Figure 6. Global QTend interval change (∆QTend) plotted against time during Valsalva, 
mental stress, handgrip and recovery after exercise in LQT1 patients (closed 
symbols) and controls (open symbols). The second vertical lines indicate the 
beginning of the recovery phases of Valsalva, mental stress and handgrip. * P < 0.05 









Figure 7. Global QTend interval change (∆QTend) plotted against HR change (∆HR) during 
Valsalva, mental stress, handgrip and recovery from exercise in LQT1 patients 
(closed symbols) and controls (open symbols). Arrows show the direction of the 
loops and line whereas R indicates the start of the recovery phase (Study III). 
ARVD patients (V). Rate corrected baseline QTpeak (327 ± 18 ms vs. 308 ± 33 ms, P 
= 0.09) and QTend intervals (398 ± 14 ms vs. 381 ± 39 ms, P = 0.24) tended to be slightly 
longer in ARVD patients than in controls. ∆QTend plotted against ∆HR formed similar 
but clearly smaller loops in ARVD patients during mental stress and handgrip, indicating 
less change in both QTend and HR during these tests in ARVD than in controls (Figure 
8). During the Valsalva manoeuvre, the corresponding loops had a different shape 







Figure 8. Global QTend interval change (∆QTend) plotted against HR change (∆HR) during 
Valsalva, mental stress, handgrip and recovery from exercise in ARVD patients 
(closed symbols) and controls (open symbols). Arrows show the direction of the 
loops and line (Study V). 
5.3 TPE intervals 
LQT1 patients (III). At baseline resting conditions, LQT1 patients and controls showed 
similar global TPE intervals (78 ± 3 ms vs. 75 ± 10 ms, P = NS). TPE intervals remained 
unchanged in both LQT1 patients and in controls in response to mental stress and 
sustained handgrip. During the strain phase of the Valsalva manoeuvre, however, TPE 
intervals prolonged in LQT1 patients whereas they did not change significantly in 
controls (Figure 9). TPE intervals also tended to prolong in LQT1 patients after supine 
exercise (Figure 9). 
 
ARVD patients (V). Although global TPE intervals were similar at baseline, ARVD 
patients had longer TPE intervals than control subjects in RV leads (73 ± 9 ms vs. 64 ± 7 
ms, P < 0.05). ARVD patients showed opposite change in global TPE intervals compared 
with controls during sustained handgrip (Figure 10), whereas it behaved similarly in both 







Figure 9. Global T wave peak to T wave end (TPE) intervals in LQT1 patients (closed 
symbols) and controls (open symbols) during Valsalva manoeuvre and exercise 
recovery. * P < 0.05 LQT1 vs. controls (Study III). 
 
Figure 10. Change in global TPE interval (∆TPE) in ARVD patients (closed symbols) and 
controls (open symbols) during sustained handgrip. * P < 0.05 ARVD vs. controls 
(Study V). 
5.4 Spatial QT dispersion 
Single-beat studies (I-II). Sympathetic activation induced by mental stress, sustained 
handgrip or cold pressor testing did not modulate dispersion of QTpeak or QTend 
intervals. However, deep breathing (Table 6) and Valsalva manoeuvre induced changes in 
spatial QT dispersion. In the ECG recordings, QTpeak dispersion was amplified during 






showed an opposite behaviour in MCG. In ECG, QTend dispersion decreased from 45 ± 
23 ms to 35 ± 21 ms (P < 0.05) during the strain phase of the Valsalva manoeuvre. In 
MCG measurements, however, QTend dispersion increased from a baseline value of 55 ± 
26 ms to 76 ± 29 ms (P < 0.05) during the bradycardia phase of the manoeuvre. Although 
QTpeak and QTend intervals measured from ECG and MCG correlated closely (r = 0.93 
and r = 0.91, respectively), there was no significant correlation between ECG and MCG 
measures of QTpeak and QTend dispersion (see also Figure 1 in Study II). 
 
 
Table 6. Effects of deep breathing phase on spatial QT dispersion in ECG and MCG 
(Studies I and II). 
 Inspiration ECG Expiration ECG Inspiration MCG Expiration MCG 
QTpeak dispersion 39 ± 15 52 ± 23* 74 ± 20 56 ± 25 
SD QTpeak 13 ± 5 16 ± 7* 17 ± 4 14 ± 6 
QTend dispersion 41 ± 18 49 ± 30 96 ± 19 73 ± 27* 
SD QTend 12 ± 5 15 ± 8 20 ± 5 16 ± 5 
Values are mean ± SD, in milliseconds. SD denotes standard deviation of the measured intervals. * P < 0.05 
inspiration vs. expiration. 
 
 
LQT1 patients (unpublished results). LQT1 patients showed more QTpeak dispersion 
than controls. QTpeak dispersion remained greater in LQT1 patients than in controls also 
during mental stress, handgrip and the late phase of exercise recovery. In the LQT1 
patients it diminished compared with baseline during mental stress and the early phase of 
exercise recovery (Figure 11). LQT1 patients and controls showed an opposite behaviour 
of QTpeak dispersion during the Valsalva manoeuvre, the former exhibiting a slight 
increase in dispersion at the beginning of strain (Figure 11). In LQT1 patients spatial 
QTpeak dispersion correlated with global TPE (R = 0.30, P < 0.001) during the 
autonomic function tests, whereas no such correlation was observed in controls. 
QTend dispersion was similar in LQT1 patients and controls. In the LQT1 group, 
QTend dispersion increased from 42 ± 12 ms to a maximum of 49 ± 15 ms (P = 0.003) 
during mental stress and from 48 ± 11 ms to 54 ± 10 ms (P = 0.050) during sustained 
handgrip, but the absolute values reached were not significantly different from those of 
unaffected subjects. 
 
ARVD patients (unpublished results). In resting measurements, ARVD patients 
showed more QTpeak and QTend interval dispersion than controls (Table 7). QTend 
dispersion decreased from a baseline value of 48 ± 20 ms to a minimum of 32 ± 17 ms (P 






minimum of 42 ± 9 s (P = 0.03) during the first minute of recovery after supine exercise, 
increasing gradually back to resting level. QTpeak dispersion behaved similarly. Neither 
measure of dispersion changed during mental stress or handgrip, but both remained 
greater in ARVD patients than in controls throughout the tests. Controls exhibited no 
significant changes in QT dispersion during any of the tests.    
 
Figure 11. Spatial QTpeak dispersion in LQT1 (closed symbols) and controls (open symbols) 
during Valsalva, mental stress, sustained handgrip and recovery from supine 
exercise (unpublished results). Values after the second vertical line represent the 
recovery phases of Valsalva, mental stress and handgrip, respectively. * P < 0.05 















Table 7. QT interval dispersion in ARVD-patients and controls at rest (unpublished 
results). 
 ARVD Control P-value 
QTpeak dispersion 50 ± 22 33 ± 17 0.08 
SD QTpeak 15 ± 8 9 ± 4 0.05 
QTend dispersion 55 ± 18 40 ± 11 0.04 
SD QTend 16 ± 6 11 ± 3 0.02 
Values are mean ± SD, in milliseconds. SD denotes standard deviation of the measured intervals. 
5.5 Interventricular QT dispersion 
LQT1 patients (IV). Table 8 shows the resting QTpeak, QTend and TPE intervals in LV 
and in RV type leads in the study groups. LQT1 patients had significantly longer QTpeak 
and QTend intervals in LV than in RV, whereas controls exhibited only a similar trend. 
On the other hand, TPE intervals were longer in RV than in LV in LQT1 patients. 
Interventricular QTpeak dispersion was greater in LQT1 patients than in controls (13 ± 9 
ms vs. 4 ± 4 ms, P = 0.03) whereas the interventricular dispersion of QTend and 
interventricular difference of TPE were similar in both study groups. 
Responses of interventricular QTpeak dispersion to the autonomic tests are presented 
in Figure 12. Interventricular QTpeak dispersion was greater in LQT1 patients than in 
controls during Valsalva and mental stress. It remained unchanged during mental stress 
and sustained handgrip but decreased to the same level as in controls during recovery 
from exercise and showed an opposite behaviour to that of controls during the Valsalva 
manoeuvre. During the Valsalva manoeuvre, the behaviour of interventricular QTpeak 
dispersion was similar to that of both TPE interval duration and spatial QTpeak 
dispersion; all three parameters showed a transient increase in the strain phase (Figure 
13). When assessed from all the tests, interventricular QTpeak dispersion correlated with 
spatial QTpeak dispersion (R = 0.44, P < 0.001) and weakly with TPE (R = 0.17, P < 
0.01) in LQT1 patients, whereas no significant correlation was observed in controls. 
Interventricular QTend dispersion was similar in LQT1 patients and controls and 












Table 8. QT intervals from left ventricular type and right ventricular type leads in LQT1 
patients and controls at rest (Study IV). 
 LQT1 (ms) Controls (ms)  
P-value 
(LQT1 vs. Controls) 
QTc peak in LV type leads  359 ± 24 325 ± 16 0.008 
QTc peak in RV type leads     346 ± 30** 321 ± 18 0.09 
QTc end in LV type leads 435 ± 24 398 ± 19 0.007 
QTc end in RV type leads   426 ± 31* 389 ± 23 0.03 
TPE in LV type leads  74 ± 4 70 ± 5 0.14 
TPE in RV type leads   78 ± 4* 65 ± 7 0.001 
QTc = rate corrected QT intervals (Bazett, QT/RR1/2). * P < 0.05 and ** P < 0.01 compared with 
corresponding intervals in LV type leads. 
 
 
Figure 12. Interventricular difference of QTpeak intervals in LQT1 (closed symbols) and 
controls (open symbols) during cardiovascular autonomic function tests. Values after 
the second vertical line represent the recovery phases of Valsalva, mental stress and 







Figure 13. T wave peak to T wave end intervals (closed symbols, solid line), spatial QTpeak 
dispersion (open symbols, dotted line) and interventricular QTpeak dispersion 
(closed symbols, dotted line) in LQT1 patients during Valsalva manoeuvre. Values 
between the vertical dotted lines represent the strain phase of the manoeuvre. 
ARVD patients (V). Table 9 presents the resting QTpeak, QTend and TPE intervals in 
LV and in RV type leads in ARVD patients and controls. Controls had longer QT 
intervals in LV than in RV type leads. Of the 9 ARVD patients, however, 6 had longer 
QTend intervals in RV than in LV (P < 0.01). Interventricular QTend dispersion was -5 ± 
13 ms in ARVD patients and 7 ± 5 ms in controls (P = 0.012), showing an opposite 
repolarization gradient in the two study groups. The corresponding values of 
interventricular TPE difference were -6 ± 4 ms vs. 3 ± 6 ms (P = 0.005). During mental 
stress, handgrip and exercise recovery this difference in interventricular QTend dispersion 
between ARVD patients and controls remained unaltered, being -7 ± 13 ms vs. 6 ± 5 ms 
(P = 0.016), -6 ± 14 ms vs. 8  ± 8 ms (P = 0.012), and -4 ± 10 ms vs. 10 ± 11 ms (P = 
0.007), respectively. Valsalva strain transiently reversed this interventricular gradient, due 
to an abrupt abbreviation of QTend intervals in the RV leads (Figure 14). Interventricular 
TPE difference behaved similarly. There were no significant differences in 
















Table 9. QT intervals from left ventricular type and right ventricular type leads in ARVD 
patients and controls at rest (Study V). 
 ARVD Controls P-value  (ARVD vs. 
Controls) 
QTc peak in LV type leads 330 ± 23 320 ± 16 0.36 
QTc peak in RV type leads  329 ± 18   316 ± 17* 0.16 
QTc end in LV type leads  395 ± 18 390 ± 21 0.61 
QTc end in RV type leads 400 ± 14     383 ± 23** 0.09 
TPE in LV type leads 67 ± 8 68 ± 7 0.94 
TPE in RV type leads     73 ± 9** 64 ± 7 0.047 
Abbreviations and symbols as in Table 8. 
 
 
Figure 14.  Interventricular difference of QTend intervals and changes of QTend intervals 
(∆QTend) during Valsalva manoeuvre in ARVD patients (closed symbols) and 
controls (open symbols). In the right panel, circles represent LV leads and triangles 







6.1 Main findings 
Global QT interval measurements from ECG and MCG showed a good correlation. 
Autonomic interventions involving deep respiratory effort or intrathoracic volume and 
pressure changes influenced ECG and MCG spatial QT dispersion differently. 
Furthermore, spatial QT dispersion measures from ECG and MCG recordings showed no 
correlation.  
 
The responses of QT and TPE intervals to autonomic function tests differed between 
asymptomatic LQT1 patients and healthy controls. LQT1 patients showed impaired 
shortening of QTpeak and QTend intervals during autonomic tests and exaggerated 
prolongation of these intervals during the recovery phases. In addition, LQT1 patients 
showed TPE prolongation during Valsalva strain and the early phase of recovery from 
exercise. The acceleration response of the sinus node to adrenergic stimulation was 
impaired in LQT1 patients, whereas the responses to vagal stimuli appeared normal. 
 
LQT1 patients had greater interventricular QTpeak dispersion than controls, and this 
interventricular repolarization gradient was transiently augmented by Valsalva strain. 
Spatial QTpeak dispersion correlated with both interventricular QTpeak dispersion and 
TPE in LQT1 patients but not in controls. Interventricular QTpeak dispersion correlated 
weakly with TPE in LQT1 patients.  
 
ARVD patients showed an interventricular repolarization gradient from RV to LV, 
which was opposite to that of healthy controls. Valsalva strain transiently reversed this 
gradient, indicating abnormal behaviour of repolarization to abrupt sympathetic activation 
and preload change in the diseased RV. ARVD patients showed greater ECG transmural 
dispersion of repolarization in RV than in LV. TPE intervals increased during sustained 
sympathetic strain and showed interventricular lability during Valsalva.  
6.2 Relation to previous studies 
6.2.1 Cardiovascular autonomic function testing in healthy subjects 
QT intervals in ECG and MCG. This was the first study reporting a direct comparison 
between simultaneous ECG and MCG recordings in QT interval measurements, showing 
a good correlation during autonomic function testing. Breathing has been observed to 
cause variation in the QT interval also in previous ECG studies (KRUPIENICZ ET AL. 1997, 






actually monitored directly ensuring that QT intervals were compared at exactly the same 
phases of inspiration and expiration. There are no previous reports on the effects of 
cardiovascular autonomic function testing on MCG recordings. 
 
Spatial QT dispersion. QT dispersion was a hot topic at the time when the first two 
studies of this thesis were conducted, with a vast number of reports being published on its 
usefulness as a non-invasive marker of arrhythmia risk in many disease states. Given the 
importance of autonomic activity as a determinant of QT interval duration, it was 
surprising that direct autonomic effects on QT dispersion had not been thoroughly 
evaluated before attempting to adopt it as a clinical tool. Only one previous study had at 
the time addressed the matter, observing no effects of reflex parasympathetic activation 
on QT dispersion. In agreement with the observations presented in Studies I-II, 
subsequent studies have reported a lack of autonomic effects on QT dispersion in healthy 
subjects (GHURAN ET AL. 2000, VAN HUYSDUYNEN ET AL. 2004). Others have observed 
augmentation of QT dispersion during catecholamine infusion (LOWE ET AL. 2001, LEE ET 
AL. 2003) and orthostatic stress (NAKAGAWA ET AL. 1999). One previous study had 
observed effects of breathing phase that were at variance with the present observations 
(KRUPIENICZ ET AL. 1997), but this might be attributable to methodological differences. 
There were only two previous studies reporting QT dispersion from MCG recordings 
(OIKARINEN ET AL. 1998, HAILER ET AL. 1999); both were clinical studies on patients with 
coronary artery disease. One of these involved a pharmacologic stress test with 
nonselective ß-adrenoceptor agonist arbutamine, which did not change QT dispersion, 
however (HAILER ET AL. 1999). 
6.2.2 Cardiovascular autonomic function testing in LQT1 patients 
QT and TPE intervals. The association between sympathetic activation and occurrence of 
arrhythmia in LQTS patients has long been recognized. However, most previous studies 
exploring the usefulness of non-invasive autonomic function testing in diagnosing or risk-
stratifying LQTS patients were conducted on non-genotyped patient populations. 
Moreover, only QTc intervals have generally been reported, making it difficult to 
interpret the true behaviour of QT intervals during autonomic challenge. The present 
work was the first study to follow the QT interval responses beat-to-beat during 
autonomic challenge in LQT1 patients. Previous experimental studies have suggested 
(SHIMIZU AND ANTZELEVITCH 2000) and clinical studies on genotyped patients later on 
have confirmed that catecholamine infusion (TANABE ET AL. 2001) or physical exercise 
(TAKENAKA ET AL. 2003) unmasks or aggravates repolarization abnormalities in LQT1, 
seen especially as an increase in TDR. In accordance with these previous observations, 
transient prolongations of QTend and TPE intervals were observed during the strain phase 
of the Valsalva manoeuvre. The impaired shortening of QT intervals observed during 
autonomic tests is in agreement with previous interpretations of QT interval behaviour at 
different HRs in ambulatory recordings (VIITASALO ET AL. 2002b). An exaggerated 






sympathetic challenge had earlier been observed after exercise testing (SWAN ET AL. 
1999a). The presently described overshoot of QTend intervals occurring during HR 
deceleration in the recovery phases of the autonomic tests might be related to increase in 
vagal activity, because similar phenomena have been observed after intracoronary 
acetylcholine (AIZAWA ET AL. 1996) and face immersion in non-genotyped LQTS patients 
(YOSHINAGA ET AL. 1999). It is tempting to ascribe this to direct vagal AP prolonging 
effects, perhaps amplified by elevated levels of circulating adrenaline. 
 
Spatial and interventricular dispersion. In the present study, spatial QTpeak 
dispersion diminished during sympathetic activation. This finding is in line with the 
observations made by Hirao and co-workers, who noted that rapid atrial pacing reduced 
the dispersion of MAPs both before and after adrenaline infusion in LQTS patients 
(HIRAO ET AL. 1996). Previously, adrenaline infusion has been reported to increase QT 
dispersion in LQTS (SUN ET AL. 1998, TANABE ET AL. 2001). Although it has been 
observed in experimental LQTS models that increased interventricular dispersion of 
repolarization is associated with TdP (VERDUYN ET AL. 1997b) and that the RV may act 
as part of the re-entrant circuit (CHINUSHI ET AL. 2001), no previous clinical studies have 
attempted to quantify interventricular dispersion or its dynamics in LQTS patients. One 
previous MCG study reported that the origin of abnormal repolarization was the LV in 
LQT1 patients (KANDORI ET AL. 2002), a finding that is in agreement with the present 
observation of an augmented interventricular repolarization gradient in LQT1. In the 
present study it was further observed that spatial QT dispersion correlated with both 
interventricular and transmural ECG dispersion of repolarization. 
 
HR responses. It had earlier been noted that LQT1 patients show diminished HR 
responses during maximal exercise testing (SWAN ET AL. 1999a) and lower HRs in 
ambulatory ECG recordings (EXTRAMIANA ET AL. 2005). The present study showed that 
an impaired sympathetic sinus nodal response is evident even in asymptomatic LQT1 
mutation carriers during relatively mild adrenergic challenge. Combined, these 
observations underscore the functional importance of IKs during sympathetic activation 
also in the sinus node. 
6.2.3 Cardiovascular autonomic function testing in ARVD patients 
Previous studies have reported anatomical (WICHTER ET AL. 2000) and functional (FOLINO 
ET AL. 2002) abnormalities of the cardiovascular autonomic nervous system in ARVD 
patients, as well as repolarization abnormalities localizing in the RV (PEETERS ET AL. 
1997, DE AMBROGGI ET AL. 1997, BOULOS ET AL. 2001). However, Study V is the first to 
describe the effects of autonomic adaptation on repolarization in ARVD patients. 
Moreover, abnormal interventricular repolarization gradients, prolonged local TPE 






6.3 Methodological considerations 
Study patients. A limitation common to all five studies of this thesis was the relatively 
small number of patients and controls. In Studies I-IV this was a necessary restriction 
owing to the labour-intensive processing of data when introducing new methods of 
assessing repolarization under dynamic conditions. The routines developed during these 
experiments have nevertheless paved the way for future studies enrolling larger patient 
populations. Importantly, the developed methods were accurate enough to detect 
significant changes between patients groups despite the limited number of patients. 
Patient selections in the substudies also imposed some restrictions regarding the 
generalizability of the present findings. Studies I-II encompassed only healthy young 
men, leaving possible gender differences unaccounted for.  In Studies III-IV, all LQT1 
patients carried the same C-terminal KCNQ1 mutation, meaning that the observed results 
may not be universal for the LQT1 subtype of LQTS. However, a homogeneous 
population in respect to the underlying mutation has the advantage of limiting variability 
caused by genotype-specific factors. In Study V, a potential confounder was the use of ß-
blockers and class III antiarrhythmic drugs. All enrolled ARVD patients were 
symptomatic prior to treatment and had documented clinical or induced serious 
ventricular arrhythmias. Therefore discontinuation of treatment merely for the purposes 
of this study was considered unethical. The use of ß-blockers definitely explained the 
blunted HR responses and partly the diminished QT responses to sympathetic challenge 
in these patients. However, exclusion of the three patients with class III antiarrhythmic 
drugs did not change the main results, indicating that these drugs had only a minor 
confounding influence. Another possible source of bias was the slight but non-significant 
difference in age between ARVD patients and their controls, as well as the presence of 
mild co-morbidities in the patient group but not in the controls. 
 
Autonomic mechanisms. Significant changes in HR and QT intervals were observed 
during the autonomic function tests, indicating that the tests caused adequate reflex 
autonomic stimulation. However, it is not possible to verify the exact autonomic 
mechanisms for a given change, considering that similar responses can be elicited both by 
sympathetic activation and parasympathetic withdrawal. This is especially true during the 
Valsalva manoeuvre, where mechanoelectric feedback further complicates the picture. It 
is also likely that autonomic tests differ in the degree of direct neural as opposed to 
humoral adrenergic activation, which may influence repolarization differently. Moreover, 
rebound parasympathetic activation may occur simultaneously with persisting 
sympathetic activation, as is probably the case during the early phases of recovery from 
sympathetic challenge. Although these combined responses limit the inferences that can 
be made regarding the extent of direct sympathetic and parasympathetic effects on 
repolarization, such response patterns closely resemble those encountered in daily living. 
 
QT interval and QT dispersion measurements. Automated QT interval measurement 
eliminates observer bias, but remains vulnerable to constant and systematic error. There 
have been concerns regarding the reliability of automated QT interval and QT dispersion 






of abnormal T waves. The QT-algorithms employed in the present studies showed high 
reproducibility both in single beat (Study I) and beat-to-beat (HEKKALA ET AL. 2006) 
measurements, facilitated partly by the relatively normal T waves encountered in the 
study patients. Moreover, leads with excessive noise or ambiguous T waves were 
carefully excluded from the analyses. Exclusion of leads potentially affects QT 
dispersion, but has nevertheless been a common practice in QT dispersion studies. 
Assessment of a global QT interval, encompassing the mean value over all measurable 
leads, provided a robust measure of autonomic influences on ventricular repolarization. 
Moreover, the averaging of 30-second beat-to-beat periods reduced the effects of outliers 
resulting from measurement error, the elimination of which is of importance especially in 
dispersion assessments. 
 
ECG markers of transmural and interventricular dispersion. TPE interval has been 
widely adopted as the ECG counterpart of TDR. Some authors have questioned this 
assumption, based on the lack of direct in vivo validation (OPTHOF ET AL. 2007) and the 
fact that any given ECG lead records not only local events but also a weighted average of 
more widespread electrical gradients. However, the good agreement between 
experimental models and clinical observations (see 2.3.6) strongly supports the relevance 
of TPE as a marker of TDR especially in LQTS. This is further underscored by the recent 
observation that TPE was the best ECG predictor of TdP in patients with acquired 
bradyarrhythmias (TOPILSKI ET AL. 2007). 
 Possible limitations in the ability of a lead or group of leads to detect local events 
apply also to the proposed new ECG marker of interventricular dispersion of 
repolarization. However, the combined observations in healthy controls, LQT1 patients 
and ARVD patients follow nicely the inferences made from previous studies (HLAING ET 
AL. 2005, KANDORI ET AL. 2002, PEETERS ET AL. 1997), emphasizing that LQTS is a 
primarily LV disease while ARVD is – by definition – primarily a RV disease. It can be 
argued that the proposed RV type leads based on QRS morphology reflect also basal and 
septal repolarization. This would be expected to reduce rather than amplify the observed 
differences in the patient groups, however. Technical restrictions at the time of study 
limited the BSPM electrode layout to only 25 precordial leads; it remains possible that a 
more extensive spatial sampling would provide an even better detection of local 
repolarization abnormalities. 
6.4 Practical implications 
The present studies have outlined physiological conditions that need to be controlled 
when assessing spatial QT dispersion. In the wake of more recent findings, the whole 
concept of spatial QT dispersion has fallen into disrepute. Nevertheless, the present 
observations indicate that spatial QT dispersion might reflect the basic underlying 
dispersion of repolarization at least in the presence of defective IKs, suggesting that earlier 






Even in the era of genetic testing, a need remains for non-invasive and simple 
diagnostic assessment of patients with known or suspected LQTS. Autonomic testing 
unmasks the abnormal repolarization in asymptomatic KCNQ1 mutation carriers, 
emphasizing on one hand the pivotal role of autonomic reflexes and on the other hand, the 
limited value of a mere resting QTc interval in the LQT1 subtype of LQTS. Even though 
a larger study is needed to address the diagnostic power of autonomic testing, the present 
work outlines new methods to deal with the complex relation between HR and QT 
responses encountered during such a setting. Combined, the present findings may provide 
a possible explanation for why symptoms in LQT1 patients commonly occur during 
swimming, where a Valsalva-like strain may happen during vagal activation elicited by 
the exposure of the face to cold water. 
A method to assess interventricular dispersion of repolarization is presented. 
Exploring its dynamics may provide new insight to possible underlying arrhythmogenic 
substrates, especially in ARVD. 
Finally, the Valsalva manoeuvre appears to be the most useful autonomic test to 
explore repolarization abnormalities. Easily performed and standardized, it could be used 
along with exercise testing and ambulatory recordings in outpatient clinics, to aid in the 
immediate management and counselling of patients with a known or suspected 







• QT intervals measured from ECG and MCG recordings show a close correlation. 
 
• Breathing movements influence the measurement of regional QT intervals in ECG 
and MCG differently. 
 
• Recovery phases of standard cardiovascular autonomic function tests and the 
Valsalva manoeuvre expose the abnormal repolarization in asymptomatic LQT1 
mutation carriers having nearly normal resting QT intervals. 
 
• Spatial QT dispersion correlates with interventricular QT dispersion and TPE in 
LQT1 patients but not in healthy controls. 
 
• ECG manifestations of defective IKs are more evident in the left than in the right 
ventricle. Abrupt autonomic adaptation amplifies the resulting interventricular 
repolarization gradient, further underscoring the labile nature of the underlying 
repolarization abnormality in LQT1.  
 
• ARVD patients exhibit an abnormal ECG interventricular repolarization gradient 
and increased transmural dispersion of repolarization in the right ventricle. 
Valsalva strain transiently reverses the interventricular repolarization gradient in 
ARVD patients. 
 
• Valsalva manoeuvre appears especially useful in revealing repolarization 
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